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Abstract 
Background 
Asthma is a common condition in general practice but is frequently under-diagnosed. There is 
wide variation in the reported incidence and prevalence rates of asthma but these rates are 
believed to be increasing. Research on the magnitude of this problem has met with 
methodological obstacles because it has been difficult to define and diagnose asthma in 
epidemiological terms.  
There is evidence that the control of asthma involving self-assessment by patients and a stronger 
doctor-patient relationship can improve compliance to therapeutic plans and lead to better 
outcomes for patients. Evidence is lacking on the influence of the level of patient empowerment 
on the quality of life and level of control of asthma. The objectives of the three studies in the 
present thesis were to assess how physicians in a sentinel practice network perform using 
standardized diagnostic criteria, to estimate the true prevalence of asthma by gender and age 
groups in the population of the area covered by one urban Health Centre in Portugal, to assess 
the severity of asthma, medication use, asthma control, the level of patient enablement and the 
quality of life in a population of asthmatic patients treated in primary care, and to study the 
relationship between enablement and the quality of life of asthma patients. 
Methods 
In the first of three studies conducted for this thesis the incidence of asthma was calculated. 
Patients consulting physicians from the Portuguese Sentinel Practice Network with complaints 
suggestive of asthma were enrolled in the study over a four year period. Frequencies of 
symptoms and diagnoses of asthma were tabulated. Diagnostic accuracy was computed by 
dividing the rate of asthma diagnosis by the true rate using established diagnostic criteria.  
In the second survey, an observational study was conducted in 2009 at the Horizonte Family 
Health Unit in Matosinhos, Portugal to calculate the prevalence of asthma. A random sample of 
590 patients, stratified by age and gender was obtained from the practice database of registered 
patients. Data was collected using a patient questionnaire based on respiratory symptoms and 
the physician’s best knowledge of the patient’s asthma status. The prevalence of asthma was 
calculated by age and gender. 
The third survey was a cross-sectional study conducted in an urban population in northern 
Portugal to assess the relationships between patient empowerment, asthma control and quality 
of life. Data were collected from both clinical records and questionnaires administered to a 
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stratified random sample of asthma patients treated in this clinic. The patient enablement 
instrument (PEI) was used to assess enablement and the asthma quality of life questionnaire 
(AQLQ) was used to assess quality of life. Asthma control was assessed using the asthma control 
test (ACT). Pulmonary function was assessed by measuring peak expiratory flow (PEF) and forced 
expiratory volume at one second (FEV1). The associations between patient empowerment, 
asthma control and quality of life were tested using linear and logistic regression models. 
Results 
In the first study 43 physicians followed 32,103 patients for 4 years and diagnosed asthma in 
310 patients. The diagnosis was confirmed in 260 cases giving a true incidence rate of 2.02/ 
1000/ year (95% confidence interval 2.12 to 2.46) and an accuracy of diagnosis of 84%. 
In the second study, data were obtained from 576 patients with a 97.6% response rate. The 
mean age for patients with asthma was 27.0 years (95% CI: 20.95 to 33.16). Asthma was 
diagnosed in 59 persons giving a prevalence of 10.24% (95% CI: 8.16 to 12.32). There was no 
statistically significant difference in the prevalence of asthma by gender. 
The third study included 180 patients. 68% of the patients were female. Over half of the patients 
(57%) had forms of persistent asthma and 43% had intermittent asthma. The mean patient 
enablement (PEI) scores were significantly higher for patients with intermittent asthma compared 
to those with persistent forms (p<0.01). There was a strong and statistically significant 
correlation between asthma control and quality of life (r2
Discussion 
 =0.64). A weak correlation between 
patient enablement and asthma control and quality of life was found.  
Asthma incidence in the Portuguese population in the first study approaches published rates. The 
prevalence of asthma found in the second study was higher than that found in some studies, 
though lower than that found in other studies. The findings of the third study confirm the 
correlation between good asthma control and quality of life. The finding of a weak correlation 
between scores on the patient enablement instrument and asthma control requires further study 
to determine if interventions to improve patient empowerment can improve asthma outcomes  
Conclusions 
Asthma is a common problem in general practice in Portugal. Adherence to international 
diagnostic guidelines can improve the rates of diagnosis. Adherence to therapeutic guidelines can 
improve asthma control and quality of life for patients. Attention to patient enablement may also 
have a role to play in the care of asthma patients. 
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Resumo em Português  
Capacitação dos doentes e gestão da asma: um estudo em medicina geral e familiar 
Introdução 
A asma é frequentemente sub-diagnosticada existindo grande variação nas taxas de incidência e 
prevalência que se pensa estarem a aumentar, mas a investigação sobre a sua magnitude tem 
encontrado obstáculos metodológicos, uma vez que tem sido difícil de definir e  diagnosticar 
asma em termos epidemiológicos. Existe evidência de que o controlo da asma envolvendo auto-
avaliação pelos doentes e uma forte relação médico-doente podem melhorar a adesão aos 
planos terapêuticos e levar a melhores resultados.  Há pouca evidência sobre a influência do 
nível de capacitação do doente sobre a qualidade de vida e o nível de controle da asma. Os 
objectivos dos estudos incluídos na presente tese foram: avaliar como os médicos de uma 
rede sentinela diagnosticam asma usando critérios padronizados de diagnóstico, estimar a 
prevalência de asma por sexo e grupo etário na população de um Centro de Saúde urbano em 
Portugal, avaliar a gravidade da asma, o uso de medicamentos, o controle da asma, o nível 
de capacitação do doente e a qualidade de vida numa população de doentes asmáticos em 
cuidados primários e estudar a relação entre capacitação e qualidade de vida nestes doentes. 
Métodos 
No primeiro estudo da tese calculou-se a incidência de asma. Os doentes que consultaram um 
dos médicos da Rede Médicos Sentinela com queixas sugestivas de asma foram incluídos no 
estudo por um período de quatro anos. As frequências de sintomas e os diagnósticos de 
asma foram calculados.  A precisão diagnóstica foi calculada dividindo-se a taxa de diagnóstico 
de asma pela taxa real usando critérios diagnóstico estabelecidos. 
O segundo trabalho foi um estudo observacional tendo sido realizado em 2009 na Unidade de 
Saúde Familiar Horizonte, em Matosinhos. Foi obtida uma amostra aleatória de 590 pessoas, 
estratificada por idade e sexo  a partir da base de dados de inscritos na USF.  Os dados foram 
obtidos através de questionários dirigidos a doentes e a médicos baseados na presença de 
sintomas respiratórios e no melhor conhecimento do médico do estado de asma do paciente. A 
prevalência de asma foi calculado por idade e sexo. 
O terceiro estudo foi um estudo transversal realizado numa população urbana no norte de 
Portugal. Os dados foram recolhidos a partir dos registos clínicos e de questionários aplicados a 
uma amostra aleatória estratificada de pacientes com asma tratados na USF. O Patient 
Enablement Instrument (PEI) foi usado para avaliar a capacitação  e o Asthma Quality of Life 
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Questionnaire (AQLQ) foi usado para avaliar a qualidade de vida. O controlo da asma foi avaliado 
pelo Teste de Controle da Asma  (ACT). A função pulmonar foi avaliada pelo débito expiratório 
máximo instantâneo (PEF) e o volume expiratório forçado no primeiro segundo (FEV1). As 
associações entre capacitação do doente, o controle da asma e a qualidade de vida foram 
testados usando modelos de regressão linear e logística. 
Resultados 
No primeiro estudo 43 médicos seguiram 32.103 utentes durante quatro anos tendo 
diagnosticado asma em 310. O diagnóstico foi confirmado em 260 casos, obtendo-se assim 
uma taxa de incidência de 2,02 /1000 /ano (IC 95%: 2,12-2,46) e uma precisão de diagnóstico 
de 84%. No segundo estudo os dados foram obtidos a partir de 576 pacientes (97,6% taxa de 
resposta). A idade média dos doente com asma foi 27,0 anos  (IC 95%: 20,95-33,16).  Foi 
diagnosticada asma  a 59 pessoas dando uma prevalência de 10,24% (IC 95%: 8,16-12,32). Não 
houve diferenças estatisticamente significativas na prevalência de asma por sexo. O terceiro 
estudo incluiu 180 doentes, 68%  do sexo feminino. Mais de metade dos doentes (57%) tinham  
formas de asma persistente e 43% intermitente. As pontuações médias do PEI foram 
significativamente maiores em doentes com asma intermitente em comparação com as formas 
persistentes (p<0,01). Observou-se uma correlação forte e estatisticamente significativa entre o 
controle da asma e qualidade de vida  (r2
Discussão 
=0,64). Observou-se uma fraca correlação entre a 
capacitação dos doentes e controlo da asma e qualidade de vida.  
A incidência de asma é semelhante à existente na literatura se forem utilizados critérios 
consensuais. A prevalência de asma encontrada foi maior do que a de alguns estudos, embora 
menor que a encontrada noutros. As conclusões confirmam a correlação entre bom controlo da 
asma e qualidade de vida. A fraca correlação entre a pontuação no PEI e o controlo da 
asma requer um estudo mais aprofundado para determinar se as intervenções para melhorar 
a capacitação do doente conseguem melhorar os resultados em saúde. 
Conclusões 
A asma é um problema comum em medicina geral e familiar em Portugal. A adesão a normas 
de orientação internacionais  pode melhorar as taxas de diagnóstico. A adesão às 
recomendações terapêuticas pode melhorar o controle da asma e qualidade de vida para os 
doentes. A atenção para a capacitação pode ter um papel a desempenhar nos cuidados 
a doentes com asma. 
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Prologue 
Family medicine covers a wide range of subjects, ranging from preventive care to the 
management of common and acute conditions. However, a considerable amount of the time 
spent in practice is used to care for patients with chronic conditions. Being a family physician in 
practice for more than twenty eight years, the management of chronic diseases has slowly 
become the main focus of my attention. 
With time, family physicians understand that the burden of chronic diseases in clinical practice is 
such that new models of care are needed. The strategies to deal with the most prevalent chronic 
conditions in the community require a knowledgeable family doctor, a well trained and structured 
health care team, motivated professionals, a national strategy for the condition and the 
enablement of patients and their families to understand and deal adequately with the different 
phases of the disease.  
Asthma is a frequent problem in the community. It offers one of the most interesting models of 
study, reflection and research for family doctors, because of its variety of shapes, different levels 
of severity, a wide age range, from the very young to the very old and the fact that in the last 
decade clinicians are able to offer much better treatment options with a higher level of control of 
the disease and a superior quality of life. 
Fourteen years ago, realising that many patients with asthma were having a less than satisfactory 
level of control than would be expected, I joined the Portuguese Global Initiative for Asthma 
(GINA) network. Slowly I became more and more interested in spreading the existing guidelines 
among health professionals and in studying asthma in the community and in my practice. 
Since 2006 I gradually became more involved with the International Primary Care Respiratory 
Group and its Research Sub-Committee in which I have been working since 2008.  
Considering the need to understand how to better manage chronic diseases, the special features 
of asthma and the professional challenges that I met in the last decade, asthma emerged as a 
natural field of research and academic development. I am happy to have had this opportunity as I 
feel that today I am more capable of caring for my patients with asthma and have also been able 
to encourage younger researchers, both medical students and registrars, to deepen their 
knowledge and initiate research in this field. 
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Introduction 
Chronic disease in the context of family medicine 
Definition of chronic disease 
Chronic disease is usually defined as a persistent or recurring disease, affecting a person for 
three months or longer. The term chronic disease commonly applies to conditions that can be 
treated but not necessarily cured. The World Health Organisation (WHO) defines chronic diseases 
as diseases of long duration and generally slow progression.
Health care providers are facing an ageing population due to the general increase in life 
expectancy, to the progress in quality of life and the improvement of health care delivery. The 
family physician of the 21
1 
st Century will have to deal increasingly more with elderly persons who 
will understandably have more chronic diseases and more co-morbidities, which will require new 
skills and different ways of organising health care.2,3
According to the WHO, chronic diseases, such as heart disease, stroke, cancer, chronic 
respiratory diseases and diabetes, are by far the leading causes of mortality in the world, 
representing 60% of all deaths.
  
1 The global prevalence of all the leading chronic diseases is 
increasing, with the majority occurring in developing countries and projected to increase 
substantially over the next two decades.
Chronic illness occupies a substantial part of the activity of family physicians in the world.
4 
5,6 The 
trend of health care development suggests there will be a significant increase in the burden of 
chronic diseases in the practice of family physicians, 7-9
Chronic diseases and the health care team 
 mostly due to the demographic changes in 
the more industrialised countries.  
Chronic diseases normally require care by one or more physicians and a health care team. 
Health professionals can offer different courses of treatment to reduce the effects of symptoms 
caused by chronic disease, but most chronic illnesses cannot be cured completely. Frequently 
the result is a lifetime of discomfort, frequent visits to the practice, medical tests, medications, 
therapies and sometimes surgeries. The cooperation of the patient plays a key role in the 
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outcome of care. The more the patient understands and learns about the condition, the better 
the outcome that can be expected. 
General practitioners frequently diagnose new cases of chronic morbidity, but are more often 
involved in the follow-up care of patients. There is an upward trend in this respect, and a 
substantial number of patients have co-morbidity. This will require patient oriented continuity of 
care. 
There are good reasons, apart from its access to populations, why general practice is well suited 
to managing chronic disease. Most patients with chronic diseases have more than one chronic 
condition.
7 
10,11 Primary care practitioners are more effective in dealing with co morbidity than 
specialist providers. General practice also offers continuity of care, which patients with chronic 
disease seek as their needs become more complex.
With adequate support from specialist services and a systematic approach, general practice / 
family medicine can provide good quality of care for patients with most high-prevalence long-term 
conditions. This has been demonstrated for patients with different chronic conditions.
 12 
 12 The role 
of a family physician that cares for patients with several co morbid conditions has also been 
recognized by patients. 
Management of chronic diseases  
13,14 
In many countries inadequate financing and lack of manpower to address chronic diseases have 
been major impediments to chronic disease control. Other impediments are the failure to provide 
key decision makers with up-to-date evidence on the burden of chronic diseases; a lack of 
understanding of the economic factors that influence chronic disease risks; and the current 
orientation of health systems toward acute care. 
Some evidence suggests that a minority of primary care patients with chronic illnesses such as 
asthma, hypertension, diabetes or depression are receiving guideline-level treatments, resulting 
in less than optimal management of their illness.
4 
Wagner et al 
 15 
16,17 have described important system barriers to high-quality care of chronic 
illnesses, including medical care being based on visits of short duration, sole reliance on the 
physician, limited access to timely expertise of medical specialists and mental health personnel, 
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inadequate access to key clinical information to help monitor patient progress and adherence, 
and lack of incentives for chronic illness outcomes. 15
Persons with co-morbid chronic diseases experience a wide range of barriers to self-care, 
including several that are specifically related to having multiple medical conditions. Self-
management interventions may need to address interactions between chronic conditions as well 
as providing skills necessary to care for individual diseases.
  
 18 Among the barriers to self-care, are  
physical limitations, lack of knowledge, financial constraints, logistics of obtaining care, a need 
for social and emotional support, aggravation of one condition by symptoms of or treatment of 
another, multiple problems with medications, and overwhelming effects of dominant individual 
conditions. Many of these barriers are directly related to having co-morbidities. 
The willingness of patients to take greater responsibility for their health may be strengthened by 
policies to give patients a choice of provider and treatments.
18 
19,20 
The importance of a new model and an innovative way of organising health teams to deal with 
persons with chronic diseases and co-morbidities has been often mentioned in the medical 
literature.
This requires a different 
organisation of health care, one that moves from the traditional episodic and reactive structure to 
a more proactive and planned model.   
The chronic care model 
 21-28 
Dealing effectively with persons with chronic diseases requires a new paradigm in designing and 
organizing health care. A shift in the orientation from a traditional model based on a disease 
centred approach towards new models of chronic care where the patients’ health problems are 
dealt with in a complementary way by the different professionals from primary to secondary 
health with community involvement and with the active participation of the patient and his 
family.
This new model should have as its major components: 1) the capacity to mobilise community 
resources to meet needs of patients - for example, encourage patients to participate in effective 
community programmes; 2) the ability to create a culture, organisation, and mechanisms that 
promote safe, high quality care - for example, promote effective improvement strategies aimed at 
comprehensive change of systems; 3) to empower and prepare patients to manage their health 
and health care - for example, use effective self management support strategies that include 
assessment, goal setting, action planning, problem solving, and follow up; 4) to assure the 
29,30 
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delivery of effective, efficient clinical care and self management support - for example, define 
roles and distribute tasks among team members; 5) to promote clinical care that is consistent 
with scientific evidence and patient preferences - for example, embed evidence based guidelines 
into daily clinical practice; 6) to organise patient and population data to facilitate efficient and 
effective care—for example, provide timely reminders for providers and patients.
An additional feature of a new model of care of chronic diseases is the increased access by 
patients to accurate health information and the right of patients to participate in the management 
of their own health information. Accessible information can be of various types such as 
information on patients’ rights, on access to health care services, on prevention, on specific 
illnesses, on the benefits and risks of participation in clinical research, information on choices 
between treatments and the risks and benefits of these choices.  
 19,24,31 
Because the person with an illness is a key element in the management of the condition, the 
chronic care model should be developed in a generalist form, oriented towards primary care, but 
patient centred. This model is known as the patient-centred clinical method and promotes an 
approach in which both the disease and the illness experience are explored, trying to understand 
the whole person, finding common ground regarding problem management, incorporating 
prevention and health promotion, enhancing the Doctor-Patient relationship while being realistic 
about the available options.
Asthma is a frequent chronic disease in all ages. Because of its variety of shapes, different levels 
of severity and age range, frequent problems with patient adherence to treatments, and the 
importance of self-care, it is one of the chronic illnesses that require better organised care. 
Considering the need to understand how to better manage asthma and the challenges that it 
poses, asthma is as a natural field of research and an excellent model of a chronic disease that 
requires considerable expertise from the health professionals and services. 
 32 
Doctor-patient relationship and patient enablement 
Patient empowerment 
The subject of patient empowerment for health is new. In the last decade it has been the focus of 
numerous research articles, opinion papers, reviews and guidelines from several organisations.  
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In 2006 the World Health Organisation collected the existing evidence on patient empowerment 
in a document named “What is the evidence on effectiveness of empowerment to improve 
health?” 33
The need for the involvement of a person with a disease in their own care is not only a matter of a 
passing trend or the simple search for a politically correct statement. It arises from the 
perception that people with chronic diseases who understand better the nature of their condition, 
how it develops and its possible complications, that are aware of the risks on inappropriate use 
or poor adherence to treatment, that are more enabled to deal with their own disease, obtain 
better results in terms of quality of life, fewer complications and use of less hospital care. 
 concluding that “health promotion should address effective empowerment strategies, 
such as increasing citizens’ skills, control over resources and access to information relevant to 
public health development; using small group efforts, which enhance critical consciousness on 
public health issues, to build supportive environments and a deeper sense of community; 
promoting community action through collective involvement in decision-making and participation 
in all phases of public health planning, implementation and evaluation, use of lay helpers and 
leaders, advocacy and leadership training and organisational capacity development; 
strengthening healthy public policy by organizational and inter-organizational actions, transfer of 
power and decision-making authority to participants of interventions, and promotion of 
governmental and institutional accountability and transparency; and being sensitive to the health 
care needs defined by community members themselves. The study concludes that the most 
effective empowerment strategies are those that build on and reinforce authentic participation 
ensuring autonomy in decision-making, sense of community and local bonding, and psychological 
empowerment of the community members themselves”. 
Patient enablement should not be simply viewed as a matter of improvement of individual control 
over one’s existence. There are good reasons to expect that more enabled patients will lead to a 
reduction of the workload of health services, allowing free time that can be used to deliver care to 
less autonomous, less differentiated, or older persons. Among these are persons belonging to 
ethnic minorities, persons with mental health problems, or those with less economical resources 
who are usually less able and, therefore, more vulnerable. 
20,34-37 
Healthier individuals, more able to deal with health promotion, disease prevention, and healthier 
life styles are also persons that will require less health care in the future. This indicates the 
importance of including the theme of patient empowerment (or enablement) in the research and 
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teaching agenda and the promotion of debate within the profession about the ways to encourage 
it.  Doctors and other health professionals could also develop strategies and skills to support the 
development of patient enablement.
Patients with chronic conditions make day-to-day decisions about self-management of illnesses. 
This reality introduces a new chronic disease paradigm: the patient-professional partnership, 
involving collaborative care and self-management education. Self-management education 
complements traditional patient education in supporting patients to have the best possible quality 
of life with their chronic condition. Whereas traditional patient education offers information and 
technical skills, self-management education teaches problem-solving skills. A central concept in 
self-management is self-efficacy--confidence to carry out a behaviour necessary to reach a desired 
goal. Self-efficacy is enhanced when patients succeed in solving patient-identified problems. 
Evidence from controlled clinical trials suggests that (1) programs teaching self-management 
skills are more effective than information-only patient education in improving clinical outcomes; 
(2) in some circumstances, self-management education improves outcomes and can reduce 
costs for arthritis and probably for adult asthma patients; and (3) in initial studies, a self-
management education program bringing together patients with a variety of chronic conditions 
may improve outcomes and reduce costs. Self-management education for chronic illness may 
soon become an integral part of high-quality primary care.
 2,38 
 39
Chamberlain defines empowerment as having a number of qualities, as can be seen in table 1.
  
40
Terminology and definition 
  
The term empowerment has its origins in the social sciences and has a considerable range of 
meanings, interpretations, definitions and disciplines ranging from psychology and philosophy 
and motivational sciences. Sociological empowerment often addresses members of groups that 
social discrimination processes have excluded from decision-making processes  
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Table 1: qualities of empowerment, according to Chamberlain 
1. Having decision-making power. 
40 
2. Having access to information and resources. 
3. Having a range of options from which to make choices (not just yes/no, either/or). 
4. Assertiveness. 
5. A feeling that the individual can make a difference (being hopeful). 
6. Learning to think critically; unlearning the conditioning; seeing things differently; 
e.g.,  
7. Learning to redefine who we are (speaking in our own voice). 
8. Learning to redefine what we can do. 
9. Learning to redefine our relationships to institutionalized power. 
10. Learning about and expressing anger. 
11. Not feeling alone; feeling part of a group. 
12. Understanding that people have rights. 
13. Effecting change in one’s life and one’s community. 
14. Learning skills (e.g., communication) that the individual defines as important. 
15. Changing others’ perceptions of one’s competency and capacity to act.  
16. Coming out of the closet. 
17. Growth and change that is never ending and self-initiated. 
18. Increasing one’s positive self-image 
 
The expression patient empowerment has been widely used to describe different states and 
levels of knowledge, understanding and action in the type of self control over one’s illness.  
As patients become aware of the lifestyle changes they will have to consent to in order to adjust 
to their disease, they may experience a distressing feeling of powerlessness. In the field of health-
care, empowerment has been acknowledged as an alternative to compliance in order to guide 
the provider-patient relationship.41
Empowerment is more often defined according to some of its anticipated outcomes rather than to 
its very nature. However, because they do not respect the principle of self-determination, most 
anticipated outcomes and most evaluation criteria are not specific to empowerment. Concerning 
the process of empowerment, analysis shows that (i) the educational objectives of an 
 The empowerment-oriented approach views patients as being 
responsible for their choices and the consequences of their choices. However, there are many 
interpretations of the term ‘‘empowerment’’, based on different understandings of the concept. 
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empowerment-based approach are not disease-specific, but concern the reinforcement or 
development of general psychosocial skills instead; (ii) empowering methods of education are 
necessarily patient-centred and based on experiential learning; and (iii) the provider–patient 
relationship needs to be continuous and self-involving on both sides. 41
Empowerment is a multi-dimensional social process that helps people gain control over their own 
lives. It is a process that fosters power in people for use in their own lives, their communities, 
and in their society by acting on issues that they define as important.
  
It is multi-dimensional in that it occurs within sociological, psychological, economic, and other 
dimensions. Empowerment also occurs at various levels, such as individual, group, and 
community. Empowerment, by definition, is a social process, since it occurs in relationship to 
others. Empowerment is a process that is similar to a path or journey, one that develops as we 
work through it. Other aspects of empowerment may vary according to the specific context and 
people involved, but these remain constant. In addition, one important implication of this 
definition of empowerment is that the individual and community are fundamentally connected.
 40.42 
From empowerment to enablement 
 42 
Recent literature has gradually been using the term enablement, rather than empowerment to 
describe the result of the doctor-patient or health team-patient interaction resulting in a higher 
level of control by patients over their own illness. It describes the capability of a person to deal 
with, understand and control his own disease and refers to the activity of encouraging and 
capacitating a patient to achieve autonomy.   
Enablement is conceptualised as an indicator of the self-efficacy benefits of consulting a doctor, 
and is expected to be associated with behaviours like treatment adherence and self-care. This is 
in contrast to satisfaction, which is conceived as a consultation outcome in and of itself. 43-46
Patient enablement does not simply relate to the management of chronic diseases. It should be 
seen in a wider sense of individual and collective promotion of independence, autonomy and self-
determination of citizens regarding their health. It refers to the capability and right of patients to 
 So, it 
is a very similar idea to empowerment, in an individual perspective of an increase in the capacity 
in relation to health care.  
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control the course of their own medical treatment and participate in the treatment decision-
making process without their health care provider trying to influence the decision. 
There are several forms of expression of the independence of the citizen in a more or less 
conscious way: 1) deciding when to see (or not see) a doctor; 2) choosing a physician or other 
health care provider; 3) Seeking a second opinion; 4) Deciding to accept or to reject a treatment; 
5) Using complementary or alternative medicines before, after or during medical treatment; 6) 
Using self-medication or over the counter (OTC) medication; 7) To interrupt a treatment. 
Enablement refers also to the capacity of a patient to accept or disagree with a physician’s 
treatment decision. The terms compliance or adherence have been used to describe the degree 
to which a patient correctly follows medical advice on treatment, prevention or changing in life-
style. In a patient-centred model of care, these concepts are gradually being replaced by the term 
concordance. 
From compliance to concordance 
According to the definition of the Royal Pharmaceutical Society of Great Britain, concordance is a 
new approach to the prescribing and taking of medicines. It is an agreement between a patient 
and a health care professional that respects the beliefs and wishes of the patient in determining 
whether, when and how medicines are to be taken. Although reciprocal, this is an alliance in 
which the health care professionals recognize the primacy of the patient's decisions about taking 
the recommended medications.
While compliance refers to something that patients do or do not do with their medicines, 
concordance refers to a relationship between two or more parties. A patient can be non-
compliant but an individual cannot be non-concordant. Only a consultation, or a discussion, can 
be non-concordant. Concordance also differs from compliance in acknowledging and valuing the 
patient's perspective. The two terms are related however, as concordance may well lead to 
improved prescribing and medicine-taking. Indeed the precise relationship between concordance 
and compliance (or adherence) needs to be carefully researched. What is already clear is that 
non-concordance can lead to non-adherence.
 47 
The introduction of the concept of concordance can promote a change in the attitudes of health 
professionals moving away from the model of compliance in which patients were only expected to 
 48 
13 
 
do as they were told. It is an approach which combines two previous strands in the compliance 
literature: doctor–patient communication and patients' health beliefs. 
The expected professional change towards a more extensive use of a patient centred model of 
care with a wider focus on patient enablement and the practice of concordance in the doctor-
patient relationship can lead to better care of patients with chronic diseases, including persons 
with asthma. 
The management of asthma in family medicine 
Definition of asthma 
Asthma is defined by the Global Initiative for Asthma (GINA) project as a chronic, inflammatory 
disorder of the airways in which many cells and cellular elements play a role. The chronic 
inflammation is associated with airway hyperresponsiveness that leads to recurrent episodes of 
wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the early 
morning. These episodes are usually associated with widespread, but variable airflow obstruction 
within the lung that is often reversible either spontaneously or with treatment.
Defining asthma for research purposes and to apply the definition to epidemiological studies 
poses a further challenge. Currently there is disagreement on the exact pathophysiology of 
asthma and, therefore, it is unclear how asthma should be exactly defined in studies. In 
epidemiology, the most common solution has been to adopt questionnaires and dichotomous 
operational definitions of asthma developed for large cross-sectional prevalence studies. 
Choosing a cut-off point for a dichotomous definition of disease is a difficult trade-off between 
sensitivity and specificity. The best cut-off point depends largely on the aims of the study.
 49 
Clinical diseases, e.g. asthma, are usually treated as dichotomies in epidemiological research. 
However, most, if not all, chronic diseases are not true dichotomies. Among asthmatics, 
continuous symptom scores have been used to measure asthma severity and asthma-related 
quality of life. However, the possibility of combining different symptoms or using a continuous 
asthma score to define asthma has been less explored.
50 
50 
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Asthma diagnosis 
Asthma diagnosis presents a challenge to the physician. Asthma has many features and is 
present in different levels of severity. In the same subject it has a considerable lifelong or even 
daily variability. Facing possible asthma symptoms, clinicians should follow a diagnostic path 
starting with a careful collection of a clinical history. In most subjects, the clinical expression is 
sufficient for a strong probability of diagnosis, but, respiratory function tests should be preformed 
as soon as possible, whenever they are available. 
Asthma should be suspected in patients with recurrent respiratory symptoms, particularly cough, 
wheeze, chest tightness and dyspnoea. Alternative diagnoses should be excluded. An objective 
lung function test such as spirometry can be used to confirm airway obstruction and to 
demonstrate reversibility of obstruction with bronchodilator medication.
The consensus from different guidelines 
51 
49,52-54
• More than one of the following symptoms – wheeze, cough, difficulty breathing, chest 
tightness – particularly if these are: frequent and recurrent; worse at night and in the early 
morning; occur in response to, or are worse after, exercise or other triggers, such as 
exposure to pets; cold or damp air, or with emotions or laughter; or occur apart from 
colds. 
 suggests that the following clinical features are 
related to the probability of asthma in those with episodic symptoms: 
• Personal history of atopic disorder 
• Family history of atopic disorder and / or asthma 
• Widespread wheeze heard on auscultation 
• History of improvement in symptoms or lung function in response to adequate therapy 
Asthma as a chronic disease 
Asthma, as defined by the WHO, is a chronic disease characterized by recurrent attacks of 
breathlessness and wheezing, which vary in severity and frequency from person to person. 
Symptoms may occur several times in a day or week in affected individuals, and for some people 
become worse during physical activity or at night.
In asthma, there is a wide variability of presenting features in different patients and in the same 
patient in different stages of the disease or according to external conditions. The unpredictability 
55 
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of the recurrence of symptoms, with some long symptom free periods followed by very 
incapacitating attacks present a special challenge for health professionals in order to provide 
adequate services that are simultaneously established and flexible to accommodate less 
concordant patients.  
Asthma control and follow-up 
As many other chronic diseases, asthma requires frequent office visits for follow-up. Deciding 
how often patients should visit has to be tailored to the level of severity and control, individual 
characteristics of the patient (personality, education, enablement), exacerbations in the recent 
past and the existence of a health care team. 
Encouraging regular review may be difficult, mostly in cases of intermittent or mild persistent 
asthma, in the absence of exacerbations, where patients fail to see the usefulness of seeing a 
doctor.   
As for many other chronic conditions, the ritual of routine visits usually includes monitoring to 
check on the progress or regression of the disease and the development of complications. Such 
checks require that we choose what to monitor, when to monitor, and how to adjust treatment.
The core of a routine review is the opportunity to identify patients with sub-optimal control and 
(for both patients and professionals) the need to adopt an approach of ‘zero tolerance’ to 
symptoms. Recognition of the inter-relationship of professional reviews and patient self-
management underpins the partnership as future management strategies are negotiated.
 56 
Monitoring is periodic measurement that guides the management of a chronic or recurrent 
condition. It can be done by clinicians, patients, or both.
57 
56
In the GINA 2009 workshop report, the Component 3 deals with assessment, treatment and 
monitoring of asthma.
  
49 The report recommends that, when asthma control has been achieved, 
ongoing monitoring should be maintained at regular intervals. No clear periodicity is defined, 
though intervals of 3 or 4 months are mentioned as the interval needed to observe the full benefit 
of most classes of control medications.49
Although monitoring is common in clinical practice, the principles of monitoring have not been 
well conceptualised, which in turn has led to suboptimal care. Chronic care could potentially be 
improved (and often at reduced costs) if for each chronic disease we determined whether and 
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how monitoring was necessary, set explicit monitoring ranges and provided appropriate graphical 
representations that aided decision making, recognised the need for different optimal intervals for 
different phases, and understood better when and how to adjust treatment to avoid the increases 
in variability caused by over adjustment.
Levels of control 
56 
Studies have shown that the use of healthcare resources, the level of lifestyle impairment, and 
quality of life, are all closely linked to the level of asthma control. With better control, there is less 
impairment, lower use of healthcare resources, and higher quality of life.
An Official joint Statement from the American Thoracic Society and the European Respiratory 
Society contributes to the definition of asthma severity and control. Asthma severity is defined as 
the difficulty in controlling asthma with treatment after exclusion of modifiable factors such as 
poor adherence, smoking, and co-morbidities. Severity largely reflects the required level of 
treatment and the activity of the underlying disease state during treatment.
58-60 
61
Asthma control encompasses not only the patient’s recent clinical state (symptoms, night waking, 
reliever use, and lung function), but also considers their ‘‘future risk’’ – that is, their potential for 
experiencing adverse outcomes, such as loss of control in the near or distant future, 
exacerbations, accelerated decline in lung function, or treatment-related side effects. It is 
emphasised that even if current poor control predicts future poor control and health care 
utilisation, other pathologic and physiologic measures, independent of the level of current clinical 
control, also influence future risk.
  
The initial Global Initiative for Asthma (GINA) treatment guideline published in 1993 and 
subsequent reports was based on disease severity grading as intermittent, mild persistent, 
moderate persistent and severe persistent asthma. Classification of asthma by severity is useful 
when decisions are being made about management at the initial assessment of a patient. It is 
important to recognize, however, that asthma severity involves both the severity of the underlying 
disease and its responsiveness to treatment.  
 61 
Because of these considerations, the classification of asthma severity is no longer recommended 
as the basis for ongoing treatment decisions. In the GINA report of 2007, and subsequent 
updates, a new approach was accepted and treatment recommendations are based on the level 
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of asthma control rather than disease severity.62
Assessing asthma control  
 The new approach classifies asthma in three 
levels of control: controlled, partly controlled and uncontrolled. 
Assessing asthma control in the physician’s office requires a combination of validated symptom-
based tests and the measurement of respiratory function such as Peak Expiratory Flow (PEF) and 
/ or the Forced Expiratory Volume in 1 second 
Asthma control can be adequately measured using the Asthma Control Questionnaire (ACQ)
(FEV1). 
63-65 or 
the Asthma Control Test (ACT).66,67 
Recently a new promising tool has been developed in Portugal, the Control of Allergic Rhinitis and 
Asthma Test (CARAT). It is a brief self-administered questionnaire used to quantify the degree of 
control of allergic rhinitis and asthma in adult patients. It is a reliable and valid instrument for 
assessing control of asthma and rhinitis in individuals in clinical practice and for comparison of 
groups of patients in research.
These questionnaires provide the patient and the physician 
with more objective measures of the level of control of the disease and the need to adjust 
treatment. They are short, well-validated questionnaires commonly used in research and in 
clinical practice. The Asthma Control Questionnaire uses five morbidity questions plus an optional 
measure of the forced expiratory volume in one second (FEV1). It has been tested for use in 
clinical practice. The Asthma Control Test uses similar morbidity questions but also includes a 
rating of overall control which includes the patient’s perspective, with a score of 20 or more 
indicating good control.  
In a discussion paper, Pinnock et al suggest that asthma reviews in primary care should 
incorporate three key steps:
68,69 
1. Assessing control in order to target care appropriately 
 57 
2. Responding to that assessment by identifying reasons for poor control and adjusting the 
management strategy accordingly 
3. Exploring patients’ ideas, concerns and expectations, and guiding self-management to 
facilitate on-going control 
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Self-management and control  
Self-management is a regular proposal of most integrated national asthma plans.49.52,63,70 The 
creators of such programmes have based their suggestions to incorporate this item in the 
existing literature, though there is contradicting evidence about its usefulness.
Some authors conclude that self management of asthma prevents exacerbations, improves care, 
and is a cost effective investment. Patient education is crucial and should be given in a 
structured way. Patients should be taught to understand their symptoms and to monitor peak 
expiratory flow at home. Patients should know how to act when signs of asthma deterioration first 
appear. There should always be supervision and continuity in asthma care.
20, 71 
35 Self-management 
lowers the burden of illness as perceived by patients with asthma and is at least as effective as 
the treatment usually provided in primary care. Self-management is a safe basis for intermittent 
treatment with inhaled corticosteroids.
Although a clinician may initiate education, it is the responsibility of all members of the team to 
provide the on-going, consistent support for guided self-management.
72 
In spite of contradictory evidence and some difficulties in reaching patient concordance due to 
some variation in professional skills, adequate management and patient’s willingness to be 
involved, guided self-management of asthma might promote better care and quality of life in 
asthmatic patients. 
 57 
The contribution of family practice to the care of patients with asthma 
National asthma programmes or guidelines recommend a high level of community involvement in 
asthma care for family physicians and community nurses. Most asthmatic patients are already 
routinely seen by family physicians. It is a frequent problem in the community, so care should 
mostly be organised at community level. Family physicians and community nurses should be 
adequately trained in asthma diagnosis, management, follow-up and referral. Other community 
health care professionals can and should be involved in the care of patients with asthma.  
Routine consultations should include a regular assessment of asthma control, reviewing the 
diagnosis, checking and correcting inhaler technique, assessing adherence, asking about, and 
treating rhinitis, adjusting therapy according to evidence-based guidelines, exploring perceptions 
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and supporting self-management and ensuring easy and fast access to professional advice 
between scheduled appointments.
The burden of asthma 
57 
According to the WHO GARD programme estimates, hundreds of millions of people of all ages 
suffer from chronic respiratory diseases which include asthma and respiratory allergies, chronic 
obstructive pulmonary disease, occupational lung diseases and pulmonary hypertension. More 
than 500 million patients live in developing countries or in deprived populations. Chronic 
respiratory diseases account for four million deaths annually. Measured in disability-adjusted life 
years (DALYs), in 2005 the burden of chronic respiratory diseases was projected to account for 
4% of the global burden and 8.3% of the burden of chronic diseases. It is estimated that 300 
million people of all ages worldwide have asthma and the prevalence has increased following 
changes to a modern, urban lifestyle. Globally, 250 000 people die of asthma every year, deaths 
being related to lack of proper treatment. Treatment for asthma is not available to all people who 
have asthma.
The burden of asthma assessed by disability-adjusted life years (DALYs), which ranks 22 
worldwide, is similar to that of other chronic diseases such as diabetes or Alzheimer disease. The 
costs of asthma are high in severe or uncontrolled asthma. Many children with undiagnosed 
asthma miss school and require emergency department visits.
73-75 
Asthma prevalence 
 73 
There are many published studies on the prevalence of asthma but the absence of a specific and 
commonly accepted definition of asthma makes reliable comparison of reported prevalence from 
different parts of the world problematic. 
In the World Health Survey from 2003,76
The 2003 Global Burden of Asthma document published on behalf of the GINA project compares 
the mean prevalence of clinical asthma in different regions.
 the prevalence of diagnosed asthma showed a narrow 
range across countries. There was a 10-fold variation in current wheezing symptom prevalence 
across countries ranging from 2.4% in Vietnam to 24.3% in Brazil. The majority of estimates fell 
within a fourfold range of prevalence, with Vietnam the lowest at 1.8% and Australia the highest 
at 32.8%.  
75 It ranges from 2.1% in Central North 
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Asia (China/Taiwan/Mongolia) to 16.1% in the United Kingdom and Republic of Ireland. 
Prevalences are higher in North America, Oceania and West and Eastern Europe than in Asia or 
Africa. Southern Africa (8.1%) and South America (9.9%) have intermediate prevalences.  
The prevalence given for Western Europe (including Portugal) is 5.9%. These studies have 
gathered data from different sources and present a rather different range of values. 
Some of the most recent publications suggest that asthma prevalence ranges from 7.2% to 
12.2%. In the U.S. National Surveillance for Asthma study published in 2007 the overall 
prevalence of asthma was 7.2%.77
Asthma incidence 
 In the discussion section of the study “Asthma in an Urban 
Population in Portugal: A prevalence study”, more data is given from prevalence surveys in 
different countries and regions.   
Asthma is a common chronic disease in childhood with a high prevalence in other age groups as 
well; however there is wide variation in the prevalence and incidence of the condition between 
and within countries. 78-83
Asthma incidence studies are rare as the estimation of the incidence of asthma presents some 
methodological problems.
  
84 The European Community Respiratory Health Survey (ECRHS) 
calculated the incidence of asthma from the reported age of the first attack of asthma and 
observed a wide variation; the incidence rate of childhood asthma (0–15 years) was found to vary 
from 1.3 to 6.7 per 1,000 person-years. The corresponding variation in the incidence of adult 
onset asthma was from 0.3 to 2.9. 81 Eagan et al recalculated a pooled estimate of the incidence 
of adult asthma of 4.6 per 1,000 person-years in women and 3.6 per 1,000 person-years in 
men.
Surveys from other countries report different results, such as the rate of 0.95 reported among 
older adults in the US,
 83 
 85 1.6 among adults in Finland,86 or 1.08 among adults in Sweden, 87 and 
5.53 reported among adults in Spain. 88 
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Asthma workload in family practice 
Asthma is a frequent health problem in the community and family doctors are especially involved 
it its diagnosis, control and follow-up. This accounts for the importance of asthma in primary 
health care. 
In a three year survey within the Portuguese Sentinel Practice Network,1 participants studied 
consultations related with asthma and the workload generated. A report of this data was 
produced for the Network and the original data was presented in the WONCA Europe Regional 
Conference in Amsterdam in 2004. 89
The scientific literature is not rich on recent data about the impact of asthma in the family 
physicians’ workload. Some studies may help to exemplify the burden of asthma in family 
medicine. In a survey from the UK, Osman et al report 38.7 consultations per 1000 person years 
at risk with a considerable age variation.
 The study design was a cross-sectional study of asthma 
related consultations with patients from the family physicians’ (FP) lists from the Portuguese 
Sentinel Network in 2000-02. 5,997 asthma related consultations were reported. There were 
18.2 consultations for each 1,000 registered patients. 58.3 % were female patients. There was 
some variability on the number of cases per participating FP. In 66.1% of the consultations there 
was a prescription renewal, in 26.4% a follow-up, in 19.6% an acute episode was reported and in 
7% there was a new case of asthma. The top therapeutic groups prescribed were inhaled beta-2 
agonists and steroids. 
 90
A Swiss study by Bollag et al, shows that the overall consultation rates for asthma per 1000 
primary care consultations increased from 1989 to 1994 then stabilized and have declined since 
2000. These figures represent the burden of consultations for acute asthma on the total number 
of consultations in the sample.
  
91
A study from the UK by Fleming et al reports data from 1989 to 1998 and concludes that new 
episodes of asthma reported to general practitioners increased between 1989 and 1993, and 
have since declined. For every 10 persons (all ages) reported with asthma there were seven new 
episodes and 22 consultations. 
  
92
  
  
                                                          
1 This survey used data from the first three years of the study Asthma incidence and accuracy of 
diagnosis in the Portuguese sentinel practice network.  
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Aims and objectives 
The aims of the thesis are: 
1. To assess the epidemiological burden of asthma in the community in order to 
understand its impact on health services and on the practices of family physicians. 
2. To describe the variety of shapes, the age range, and the different levels of severity of 
asthma to be able to offer patients better treatment options, a higher level of control of 
the disease and better quality of life. 
3. To understand the relationship between patients’ enablement and the level of control of 
asthma and the quality of life to be able to develop adequate clinical strategies to deal 
with the disease. 
4. To confirm the feasibility of using questionnaires and clinical tools to measure asthma 
control and patient enablement and wellness in the context of the family practice 
consultation. 
These general aims lead to some more specific objectives: 
1. To assess the quality of the diagnosis of previously reported new cases of asthma in 
patients of family physicians belonging to the Portuguese Sentinel Network in 2000-2002 
using a questionnaire on diagnostic criteria. 
2. To estimate the incidence of asthma in Portugal over a four year period (2000-02). 
3. To contribute to the validation of data of the Sentinel Network. 
4. To determine the prevalence of asthma by gender and stratified age groups in the 
Horizonte Family Health Unit in Matosinhos Portugal in 2009.  
5. To assess the severity of asthma, the use of medication and quality of life in a population 
of asthmatics. 
6. To study the factors that influence the level of enablement of patients with asthma. 
7. To study the effect of enablement on the quality of life and level of disease control in a 
population of asthmatics. 
8. To estimate the different degrees of enablement and their impact on morbidity.  
9. To plan future research on asthma that constructs a continuing research line in clinical 
and academic family medicine. 
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Methods 
The complementary nature of the three studies in this thesis 
The methods used in the three studies included in the current thesis are described in the 
published reports of these studies. The methods used are different, though complementary. 
Together, they allow an overview of the central features of asthma in society, from the description 
of its incidence and prevalence to the outcomes of individual care in a family practice setting.   
The study, “Asthma incidence and accuracy of diagnosis in the Portuguese sentinel practice 
network” was developed within the framework of the Portuguese Sentinel Practice Network 
(PSPN). The study used a convenience sample of physicians and patients from a research 
network. A doctor-based diagnosis was made with no patient input, as the study used routine 
data collected by family physicians in clinical encounters. The researchers observed, described 
and analysed data but did not have full control over its quality.  
This study was an original approach to the routine collection of data by the PSPN. The Sentinel 
Network is an important epidemiological tool that allows the surveillance of health problems for 
which other sources of data are missing or deficient. However it has some limitations. The quality 
of the routine data collected by the PSPN has been discussed in the literature. 93
The Network uses a weekly report sent by mail or inserted in an internet-based form to conduct 
its studies. Each participating physician records the events of interest that occur in their 
registered patients. The PSPN coordinating team collects information about the patient list of 
each participant, calculating the workload of each physician and estimating the incidence of the 
conditions studied.  
 It is important to 
understand these limitations to be able to develop research that goes beyond the routine 
collection of data.  
A study on asthma in family medicine was done in the PSPN. After the routine collection of data 
was concluded and reports of the first phase had been produced for the Network, the authors 
concluded that the number of reported rates and incidence estimates of asthma had a large 
variability among participating physicians. During the discussion at the network general meeting, 
it was apparent that variation in diagnostic criteria had an influence on these results. Doubts 
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were raised regarding the ability of the Network to study asthma incidence through routine data 
collection. 
As a result, a satellite study was proposed. Each of the physicians that had participated in the 
routine data collection on asthma was later-on asked to report on the diagnostic features for all 
the newly diagnosed cases of asthma, as described in the published survey.  
A new questionnaire was developed for this purpose and data was gathered through the usual 
Network method. Each participating physician accepted to review their data and the diagnostic 
criteria used. This critical evaluation resulted in more accurate information on the diagnostic 
criteria.  
This is an approach that could easily be replicated to the study of other chronic diseases. 
Sentinel networks routinely collect and process a large amount of data but a deeper and more 
structured observation is needed in order to achieve a higher accuracy.  
The study, “Asthma in an Urban Population in Portugal: A prevalence study”, was designed to 
calculate the prevalence of asthma using a different and innovative approach. The motivation for 
this survey was the poor quality of the available information about asthma prevalence in Portugal. 
In previous surveys carried out in Portugal, before 2006, studies included limited age groups or 
used methodologies which provided questionable estimates of the prevalence rates. 
A combination of a medically verified asthma diagnosis using medical records and the use of self-
reported symptoms with the ISAAC questionnaire helped to gather the best available knowledge 
about asthma from both patients and physicians.  
The researchers studied a practice population using a random sample of registered patients with 
replacement of non-responders. Data were collected using two questionnaires: a physician 
questionnaire and a patient questionnaire. The diagnostic procedures were based on a 
combination of the answers given by the patient on respiratory symptoms and the physician’s 
knowledge of the patient’s asthma status. It was possible to control data quality and to include 
clinical information obtained from both patients and doctors. Stricter diagnostic criteria were 
applied, resulting in a combination of data from different sources that allowed a more precise 
diagnosis.   
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Unlike many other surveys that have relied on either the physicians’ information or on the 
patients’ knowledge about the disease, this study obtained the best possible data from both 
sources. 
The study “Enablement and quality of life in asthma patients (the EQLAP study): a cross-sectional 
study from a family practice”, aimed at assessing the severity of asthma, medication use, asthma 
control, the level of patient enablement and the quality of life in a population of asthmatic 
patients treated in primary care, and to study the relationship between enablement and the 
quality of life of asthma patients. 
The study used a random sample of patients extracted from a data base of patients with known 
asthma. Clinical information on patient behaviour, attitudes, and measures of quality of life were 
obtained. Each patient was individually interviewed and objective measures of respiratory function 
and disease control were gathered. This study represents a transition from a research stance that 
seeks to measure diagnoses and disease control, to one that seeks to understand the point of 
view of patients and to study their attitudes and behaviour. The former approach has been used 
in many published studies.  The new approach in an area of study where research tools are not 
yet fully developed requires special attention to study design and validation and calibration of 
study questionnaires and an understanding of models of relationship and causation. These are 
two different and complementary approaches which can enhance our understanding of asthma.  
These studies complement each other by evolving from population epidemiology, through clinical 
assessment into patient centred measures of well being and enablement. They connect broad 
knowledge from epidemiological data to clinical practice and the individual patient. The 
connecting line is the understanding of how the knowledge about the burden of disease in the 
general population helps doctors in clinical practice. This information can be combined with 
patient-centred clinical measures to empower the family physician with additional tools to obtain 
better control of asthma and improve the quality of life of patients.  
  
28 
 
  
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
  
30 
 
  
31 
 
Results 
Overview of the studies completed by the candidate 
This section is an overview of the results of the three studies that comprise this thesis. The 
description of the results of the third paper is longer than the version submitted for publication to 
present additional material relevant to the understanding of patient empowerment, asthma 
control and quality of life. 
The first survey, Asthma incidence and accuracy of diagnosis in the Portuguese sentinel practice 
network aimed to assess how physicians in a Portuguese sentinel practice network perform using 
standardised diagnostic criteria. It studied patients consulting with the network physicians with 
complaints suggestive of asthma over a four-year period. Symptom frequency and diagnoses of 
asthma were tabulated and diagnostic accuracy was computed by dividing the rate of asthma 
diagnosis by the true rate using established diagnostic criteria.   
Asthma incidence in Portugal was calculated and the value obtained was close to published rates 
if accepted criteria are used. 
The second study had the title: Asthma in an Urban Population in Portugal: A prevalence study. 
Its aim was to estimate the true prevalence of asthma by gender and age groups in the 
population of the area covered by one urban Health Centre in Portugal and to estimate the 
national prevalence of asthma. An observational study was conducted in 2009. A random sample 
of patients, stratified by age and gender was obtained from the practice database of registered 
patients. Data were collected using a patient questionnaire on respiratory symptoms and the 
physician’s best knowledge of the patient’s asthma status. The prevalence of asthma was 
calculated by age and gender. 
The prevalence of asthma found in the present study was higher than that found in some studies, 
though lower than that found in other studies.  
The third study was called Enablement and quality of life in asthma patients (the EQLAP study): a 
cross-sectional study from a family practice 
The study was a cross-sectional study conducted in an urban population in northern Portugal. 
Data were collected both from clinical records and questionnaires administered to a stratified 
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random sample of asthma patients treated in this clinic. The modified Patient Enablement 
Instrument (mPEI) was used to assess enablement and the Asthma Quality of Life Questionnaire 
(Mini-AQLQ) was used to assess quality of life. Asthma control was assessed using the Asthma 
Control Test (ACT). Pulmonary function was assessed by measuring peak expiratory flow (PEF) 
and forced expiratory volume at one second (FEV1). 
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Corrigendum 
 
Error in Asthma incidence and accuracy of diagnosis in the Portuguese sentinel 
practice network by Correia de Sousa et al. Primary Care Respiratory Journal (2010); 
19(4): 352-357. 
 
The abstract, the results section and the conclusions section correctly state that the 
diagnostic accuracy of the physicians in this study was 84%.  
 
The erroneous figure of 62% appears in the first paragraph of the discussion section 
on page 354 and again at the bottom of page 356 when referring to diagnostic 
accuracy. 
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Abstract
Aims: Asthma is frequently under-diagnosed with a wide variation in incidence rates. We aimed to assess how physicians in a Portuguese
sentinel practice network perform using standardised diagnostic criteria.  
Method: Patients consulting one of the 43 network physicians with complaints suggestive of asthma were enrolled in the study over a
four-year period. Symptom frequency and diagnoses of asthma were tabulated. Diagnostic accuracy was computed by dividing the rate
of asthma diagnosis by the true rate using established diagnostic criteria.
Results: Over four years, 43 physicians followed 32,103 patients (128,412 patient-years) and diagnosed asthma in 310. The diagnosis was
confirmed in 260 cases, giving a true incidence rate of 2.02/1000/year (95% confidence interval 1.8 to 2.2) and an accuracy of diagnosis
of 84%.
Conclusions: Asthma incidence approaches published rates if accepted criteria are used. Educational efforts to ensure more accurate
diagnosis may improve outcomes for asthma patients.
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Introduction
Asthma is the most common chronic disease in childhood
worldwide with a high prevalence in other age groups as well,
yet there is wide variation in the prevalence and incidence of
the condition between and within countries.1-5 Making the
diagnosis of asthma is necessary to ensure correct treatment
and improvement in quality of life. Accepted diagnostic
criteria for asthma are available but are not widely applied.6
One way of standardising the diagnostic process is by the use
of research criteria or research protocols by groups of physicians.
This is the method used in sentinel research networks in which
participating doctors agree on diagnostic criteria for one or more
conditions to allow for surveillance or study of these conditions
in normal practice. The Portuguese Sentinel Practice Network
(PSPN) is one such research network. It has been in existence
since 1980 and currently has 145 members.7 It is a Health
Observation System consisting of family physicians. The
objectives of the network are to estimate incidence rates for
diseases or conditions occurring in the sentinel physicians’
patient lists, to participate in the epidemiological surveillance of
diseases occurring in the community, to identify potential
outbreaks, and to build a database that allows the
epidemiological analysis of diseases with public health interest.
Following the Global Initiative for Asthma (GINA) workshop in
1995,8 there was an increased awareness in Portugal of the need
for better knowledge of the burden of asthma. Multidisciplinary
GINA groups were formed in order to disseminate the guidelines
and to develop educational activities on asthma diagnosis and
control. There were no readily available data on the incidence of
asthma in Portugal, and the Portuguese National Plan for Asthma
Control9 had not yet been published. The plan included an appeal
for an ongoing epidemiological survey of asthma.
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In 1999 the PSPN decided to study the incidence of new
cases of asthma presented to members of the network over a
four-year period. This paper presents data from this network
study and explores the question of diagnostic accuracy of
asthma by network members. We wished to determine the
incidence of asthma in this population and, in particular, to
validate the diagnosis of asthma made by general practitioners
(GPs) using accepted diagnostic criteria as a standard.
Methods 
In 1999 the Portuguese Sentinel Practice Network agreed to
conduct a study on the incidence of asthma in network practices.
Participation in the network is voluntary and there are two types
of co-operation: weekly notification of new cases from the
participating practices; or participation in national and
international studies proposed by the participants. Data is
collected during routine consultations. Network members report
findings via the Internet or by using regular mail to a co-ordinating
team located at the Portuguese National Institute of Health (INSA).
The Portuguese Association of Family Physicians is also a partner
in the project. 
Comparison of the study population with the
Portuguese population during the study period
The composition of the study population followed by the
PSPN was compared to the composition of the Portuguese
population in 2003 using national census data10 and was
found to be similar. Young patients aged 0 to 14 years are
slightly over-represented in the research network population
constituting 15.4% of the network population compared to
14.8% in the general population. Patients over 65 years of
age were also over-represented – 18.4% compared to 16% in
the general population. Patients in the 15-65 year age group
were underrepresented in the study population (66%)
compared to the general population (67%). As a result,
incidence rates were standardised by age to the Portuguese
population in 2003.
Data collected by the reporting physicians during the first
network study on asthma (2000-2003) were collated and
validated in 2004. A first report was produced in 2005.
Because a wide variety of rates of new cases of asthma  were
reported by study participants, the authors decided to
conduct a second study in order to assess the diagnostic
accuracy of new cases of asthma and to validate the
incidence rate.
During the study period, the population of the sentinel
practices remained relatively stable with an increase of 13
patients per practice per year or less than 1% of the average
practice size of 1596 patient per doctor (personal
communication, Isabel Falcão, Portuguese Sentinel Practice
Network).
In 2005, all physicians reporting at least one new case of
asthma during the study period were asked to participate in
this study. Data were collected retrospectively from all
participants. Physicians were asked to report demographic
data on each patient including age and gender. Diagnostic
criteria for the diagnosis of new cases of asthma were
collected. These included items in the history including cough
and night-time wheezing, items in the physical examination
such as expiratory wheezing, and items from additional
examination such as peak expiratory flow (PEF) measurement,
spirometry and skin testing. In addition, data from referrals to
hospital specialists and the type of specialist were recorded
along with the place of diagnosis of asthma.
The criteria used for the diagnosis of asthma in this study
were the GINA criteria published in 2005.8 A definite
diagnosis of asthma was made in the presence of at least one
positive item from the medical history, one from physical
examination and one from additional tests (see sections 1, 2
and 3 in Table 2). A probable diagnosis of asthma was made
if one item was present in only two out of three categories.
The incidence rate per thousand persons was calculated
by dividing the number of definite or probable cases of
asthma reported by the total number of patients in the
population under observation during the four year study
period x 1000. The annual incidence was computed by
dividing this rate by 4 and was standardised by age and sex
for the Portuguese population in 2003. Comparisons of
incidence rates by gender were made using the Student t-test
with significance set at the p<0.05 level.
Results
Over a four-year period, 43 physicians participating in the study
followed an average of 32,103 patients per year, representing
128,412 patient years of observation. This represents 0.3% of
the 10,569,592 inhabitants living in Portugal in 2005.11 During
the study period, 310 new cases of asthma were reported. The
260 cases reported by the 43 network physicians represent a
mean of 5.66 new asthma cases (95% CI 3.95 to 7.37) reported
by each physician with a range of 1 to 26 cases reported per
physician.
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Mean age 34.1 years, 95% CI [31.51-36.71], sd 23.29
Males 29.08 years, 95% CI [24.92–33.25], sd 24.11
Females 37.79 years,  95% CI [35.54-41.04], sd 22.02
Median age 33 years
Age range 0 to 85 years
T-test for difference in mean age between genders: t= 3.30; p= 0.001;
mean difference 8.7 years; 95% CI [3.52-13.89]
Table 1. Characteristics of the newly diagnosed
asthmatic patients (n=310).
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The characteristics of the newly-diagnosed asthmatic
patients are presented in Table 1. The mean age of the patients
was 34.11 years (95% CI 31.51 to 36.71 years, s.d. 23.29
years, range 0 to 85 years) and 57.7% of the patients were
female. The mean age of newly-diagnosed male asthmatics
was significantly lower than the mean age of newly-diagnosed
females (29 years vs. 38 years, p<0.01).
The diagnostic criteria used to make the diagnosis are listed
in Table 2 which presents the frequency of symptoms, physical
signs and laboratory findings encountered. Recurrent
wheezing was the most common symptom recorded. The
place of diagnosis and the specialty of the diagnosing physician
are also given in Table 2. The primary care setting was the most
common setting for diagnosis (in 60% of cases) with the
diagnosis being made by a family physician (GP) in 56.8% of
cases. The diagnosis of asthma was positive or probable in 260
new cases of asthma reported. This included 110 males and
150 females.
The corrected asthma incidence rate for all ages was found
to be 2.02 cases per 1,000 persons per year (95% CI, 1.8 to
2.2). For males the incidence was 1.8/1,000 persons/year (95%
CI, 1.5 to 2.1) and for females 2.23/1,000 /year (95% CI, 1.8
to 2.6).The difference in incidence by gender was statistically
significant (p=0.01).
The incidence of asthma by age varied from a maximum of
5.93 in the age group 0 – 4 years to a minimum of 0.93 in
those over 75 years (Table 3). Asthma incidence was higher in
males in the younger age groups and higher in females in the
older ages.
The proportion of patients meeting the diagnostic criteria
for asthma is given in Table 4. All diagnostic criteria for asthma
were present in 50% of the cases diagnosed. Most criteria
were present in 29.7%. The diagnosis was confirmed by a
hospital consultant in an additional 4.2% of cases. Therefore,
asthma diagnosis was positive or probable in 83.9% of cases.
Discussion
This study found that the annual incidence of asthma in the
general population in Portugal was 2.02 cases/1000 using data
collected from a large sentinel practice network. It also found
that the accuracy of the diagnosis by family physicians/GPs was
62% using accepted diagnostic criteria. We believe this is the
first report of this nature from Portugal.
Asthma incidence studies are infrequent, since the
estimation of asthma incidence presents some methodological
problems.12 The European Community Respiratory Health Survey
(ECRHS) calculated the incidence of asthma from the reported
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Number (%) positive
Wheezing 179 (59.7%) 
High-pitched expiratory whistling sounds– 
especially in children.
History of one of any of the following:
Cough (worse particularly at night) 184 (59.4%)
Recurrent Wheeze 216 (69.7%)
Recurrent difficulty in breathing 208 (67.1%)
Recurrent chest tightness 69 (22.3%)
Demonstration of reversibility of airflow 
obstruction with a short-acting bronchodilator by:
Clinical  observation 214 (69%)
Peak expiratory flow 58 (18.7%)
Spirometry 68 (21.9%)
Who made the diagnosis?
Family Physician 176 (56.8%)
Pediatrician 28 (9%)
Pneumologist 25 (8.1%)
Allergologist 24 (7.7%)
Other 19 (6.1%)
Table 2. Diagnostic criteria for asthma used in this study.
Age group Males Incidence Females Incidence M + F Incidence 
00-04 25 7.58 13 4.18 38 5.93
05-09 10 3.11 9 2.71 19 2.91
10-14 11 3.21 6 1.77 17 2.49
15-24 14 1.66 20 2.33 34 2.00
25-34 7 0.69 23 2.22 30 1.47
35-44 15 1.64 27 2.73 42 2.21
45-54 10 1.29 14 1.72 24 1.51
55-64 7 1.13 19 2.62 26 1.94
65-74 8 1.37 13 1.78 21 1.60
75 + 3 0.80 6 1.01 9 0.93
TOTAL 110 1.80 150 2.23 260 2.02
Table 3. Asthma incidence (new cases per 1000 persons) by age, 2000-2003.
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age of the first asthma attack and observed a wide variation; the
incidence rate of childhood asthma (0–15 years) varied from 1.3
to 6.7 per 1,000 person-years. The corresponding variation in
the incidence of adult onset asthma was from 0.3 to 2.9.13
Eagan et al. recalculated a pooled estimate of the incidence of
adult asthma of 4.6 per 1,000 person-years in women and 3.6
per 1,000 person-years in men.5
Internal validity  
Portuguese family physicians have relatively stable patient
lists. The age-gender distribution of the lists is updated yearly
and reported to the Portuguese Sentinel Practice Network
(PSPN) coordination centre. The PSPN uses the participating
physicians’ lists as a denominator for estimating incidence
rates. Whenever participating doctors are absent for
prolonged periods from their practices, their lists are removed
from the denominator for statistical purposes. During the
study period there was a mean change in list size of less than
1% per year per practice.
Questionnaire / diagnostic criteria
The diagnostic criteria for asthma used in this study were the
criteria listed in the 2005 GINA guidelines. They have been
adapted further for use in primary care by the IPCRG in 200614
and further updated by GINA in 2008.15 Future study of
asthma incidence should use the latest diagnostic criteria.
Comparison of findings with other published studies
This study found an annual incidence of asthma of 2.02 cases
per 1000 population per year. This is higher than the rate of 0.95
reported among older adults in the US,16 1.6 among adults in
Finland,17 or 1.08 among adults in Sweden.18 However, it is less
than the rate of 5.53 reported among adults in Spain.19 The
figures in this study are similar to findings among adult patients
in two studies conducted in the USA.20,21
It is difficult to compare incidence among similar age
groups in different studies because of the different age
intervals used. Eagan et al. reviewed data from several studies
in 2005 and presented a comparison of the findings. Very few
studies have comparable data to the present one in terms of
the age groups covered. The paper by McWhorter et al.21 has
comparable data which can be seen in Table 6.
Table 7 presents data from different sources in order to
allow a comparison with the PSPN study.
There are several questions arising from the high incidence of
asthma in small children found here. There are considerable
diagnostic difficulties in this age group. Often physicians
diagnose asthma at an older age and retrospectively attribute
the onset of asthma to a specific year. In the PSPN study the
incidence rate in the age group 1-14 years was 3.74 cases per
1000 per year, considerably higher than the 1.4 cases/1000/year
found by Yunginger et al. in 1992.20 The PSPN study observed a
higher incidence rate in the age group 0 – 4 years (5.93
cases/1000/year). It is possible that some of the children
diagnosed with asthma were suffering from recurrent wheezing
or bronchiolitis. These findings raise the possibility of over-
reporting in this age group.
In this study, the incidence rate among patients over 65
years of age is 1.31/1,000/year. This is slightly higher than the
incidence found in the USA in 1997.20 Eagan et al. also
suggest that the incidence of asthma in the elderly has
previously been under-estimated.5
Our findings follow the pattern reported previously – with
higher rates of asthma in boys than in girls and lower rates in
men than in women.22
Accuracy of diagnosis
Given the difficulties in diagnosing asthma, one of the aims
of the present study was to validate the diagnosis of asthma
made by GPs working in the primary health care setting.
While a number of studies suggest that there is under-
diagnosis of asthma in children, adolescents and adults, little
research has been conducted on the over-diagnosis of
asthma. Symptoms similar to those seen in asthma can be
found in other lung diseases such as emphysema and chronic
n %
All criteria present 155 50.0
Most criteria present 92 29.7
Diagnosis confirmed by hospital consultant 13 4.2
Diagnosis not confirmed 50 16.1
Total 310 100.0
Table 4. Proportion of patients meeting diagnostic
criteria for asthma.
Age group Males standardised Females standardised 
incidence rate/ incidence rate/
1000/year 1000/year
0 to 14 years 4.6 2.8
15 to 64 years 1.2 2.3
65 and over 1.2 1.5
Table 5. Asthma incidence standardised by age and sex
to Portuguese population of 2003.
Age group (years) PSPN, 2004 McWhorter, 198821
25-34 1.5 1
35-44 2.2 1.4
45-54 1.5 1.9
55-64 1.9 3.1
65-74 1.6 3.7
Total 1.75 2.1
Table 6. Comparison of asthma incidence rate (new
cases per 1000 people) between the PSPN study and the
study by McWhorter et al.21
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bronchitis.23 These symptoms may also appear in patients with
cardiac failure, pulmonary tumours or hyperventilation
syndrome. The diagnostic accuracy found in this study was
83.9%. This figure is lower than that found by Ward et al.24
whose sample was limited to individuals aged 16 – 45 years
in order to reduce the effects of diagnostic uncertainty in
children and confusion with COPD in older patients. This may
explain the difference in the rates.
The accuracy of diagnosis in the present study was higher
than that found by Montnémery et al. (76.5%),25 but their
study involved over 100 general practices compared to 43
physicians in the current study – and this might explain the
differences in diagnostic accuracy between the two studies.
Marklung et al. reported a diagnostic accuracy of 66% over a
two year period,23 but their study involved only 86 patients
compared to 310 in the current study.
We used existing international guidelines8 for the definition
and diagnosis of asthma when the first report of the study was
completed in 2005. Due to the limitations of guidelines,26,27 the
difficulties encountered by physicians in adhering to them,28 and
difficulties in clinical practice in managing asthma in line with
recommendations,29 the International Primary Care Airways
Group (IPAG) produced its own guidelines for primary care
physicians in 2005.30 Together with the IPCRG guidelines,14 these
provide a more practical approach than the GINA Guidelines.
They add clinical assessment, continuity of care, and the best
knowledge of the family history to help make the diagnosis of
asthma. The IPCRG recommendations14 remain an excellent tool
for the management of asthma and other respiratory conditions
in primary care even after publication of the 2006 GINA update.31
Implications for future research 
This study has implications for clinicians, researchers and
patients. A incidence of 2 new cases per 1000 persons per
year with a diagnostic accuracy of 62% suggests that there is
considerable under-diagnosis of a common, treatable
condition. Patient education to improve recognition and
reporting of important symptoms to their physicians, and
education of practitioners in the use of valid diagnostic
criteria, may help increase the rate of diagnosis and improve
patients’ quality of life by providing them with effective
treatment. Further research that focuses on effective
education for the public and healthcare professionals, and
effective application of existing standards for the diagnosis
and treatment of asthma, is also required.
Conclusion
Data from the current study suggest that the diagnoses of asthma
made by the family physicians in the PSPN were accurate in 84%
of all reported cases with reference to the diagnostic criteria used.
The incidence rate reported here falls within the range of values
reported in the literature from other countries. Based on these
data we may expect 20,250 new cases of asthma per year in
Portugal. If so, there is probably marked under-diagnosis of this
condition in practice. This suggests the need for an educational
campaign to make the diagnostic criteria more widely known and
to provide support for practitioners in making the diagnosis. With
the effective treatments now available, a campaign for more
accurate diagnosis and the application of evidence-based
guidelines for treatment would have the potential to improve
quality of life for a large segment of the population.
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Author / year Location Age group Incidence rate /1000 PSPN 2004
McWhorter, 198821 USA (NHANES I) 25-74 2.1 1.75
Yunginger, 199220 USA 1-14 1.4 3.7
Bauer, 199716 USA >65 0.9 1.3
Ronmark, 199732 Sweden 35-66 5
Huovinen, 199917 Finland 18-45 1.6
Basagaña, 200119 Spain 20-44 5.5
Eagan, 200233 Norway 15-70 3.2-3.6
RHINE Study, 200434 Sweden, Norway, Denmark, Iceland and Estonia 30-54 2.2
de Marco, 200535 Italy 20-44 1.5
Eagan, 20055 Several countries Several (pooled data) 3.6-4.6
Thomsen, 200536 Denmark 12-41 5.5
Table 7. Comparison of asthma incidence rate between the PSPN study and other studies.
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Abstract
Background: The prevalence and incidence of asthma are believed to be increasing but research on the true
incidence, prevalence and mortality from asthma has met methodological obstacles since it has been difficult to
define and diagnose asthma in epidemiological terms. New and widely accepted diagnostic criteria for asthma
present opportunities for progress in this field. Studies conducted in Portugal have estimated the disease
prevalence between 3% and 15%. Available epidemiological data present a significant variability due to
methodological obstacles.
Aim: To estimate the true prevalence of asthma by gender and age groups in the population of the area covered
by one urban Health Centre in Portugal.
Method: An observational study was conducted between February and July 2009 at the Horizonte Family Health
Unit in Matosinhos, Portugal. A random sample of 590 patients, stratified by age and gender was obtained from
the practice database of registered patients. Data was collected using a patient questionnaire based on respiratory
symptoms and the physician’s best knowledge of the patient’s asthma status. The prevalence of asthma was
calculated by age and gender.
Results: Data were obtained from 576 patients (97.6% response rate). The mean age for patients with asthma was
27.0 years (95% CI: 20.95 to 33.16). This was lower than the mean age for non-asthmatics but the difference was
not statistically significant. Asthma was diagnosed in 59 persons giving a prevalence of 10.24% (95% CI: 8.16 to
12.32). There was no statistically significant difference in the prevalence of asthma by gender.
Conclusion: The prevalence of asthma found in the present study was higher than that found in some studies,
though lower than that found in other studies. Further studies in other regions of Portugal are required to confirm
these findings.
Keywords: Asthma, Prevalence, Portugal
Background
Asthma is a common chronic disease world-wide with a
high prevalence in all age groups, mostly in children and
young people yet there is wide variation in the prevalence
of the condition between and within countries [1-8].
Asthma prevalence and incidence are believed to be
increasing [9-11], though this view is controversial
[2,12,13].
Asthma is also an important reason for hospital
admission [14,15] and causes considerable limitations on
the physical, emotional, social, and professional lives of
both patients and their families, interfering with normal
activity and quality of life [16,17].
Available epidemiological data on the incidence, preva-
lence and mortality from asthma present significant
variability as research has met with methodological
obstacles since it is difficult to define and diagnose
asthma in epidemiological terms [2,18,19]. Some studies
used non-standardized questionnaires while other
included patients after a pulmonary function assessment
or proof of bronchial responsiveness. Because of the dif-
ferences in methodology, considerable differences of
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prevalence have been found in different studies. New
widely accepted diagnostic criteria for asthma present
opportunities for progress in this field.
The Global Initiative for Asthma (GINA) lists some
actions required to reduce the burden of asthma. One
task is to recognise asthma as an important cause of
morbidity, economic cost, and mortality worldwide and
to measure and monitor the prevalence of asthma, and
the morbidity and mortality due to asthma throughout
the world [2].
The Portuguese Asthma Control Program was devel-
oped in 2000 [20] and, in line with the GINA proposal,
recommended regular studies on epidemiological and
clinical follow up of asthma. The Portuguese Guidelines
on the diagnostic and control of asthma, based on the
existing GINA Guidelines, were also published in 2000
[21] and were updated in 2007 [22] after the 2006
changes of the GINA Report.
Several studies conducted in Portugal have estimated
the disease prevalence as ranging from 3.3% to 15%
[23-32]. Most of the Portuguese data available were
obtained before 2006, covered limited age groups or were
obtained using methodologies with questionable accuracy
of the prevalence rates.
This study was conducted to determine the prevalence
of asthma by gender and stratified age groups in the
Horizonte Family Health Unit in Matosinhos Portugal
in 2009 to increase our knowledge of the epidemiology
of asthma.
Method
Study population
Matosinhos, Portugal is a suburb of the city of Porto with
a population of 169,261 inhabitants in 2008. The age and
gender distribution of Matosinhos is similar to that of
the total Portuguese population [33]. The population of
the Horizonte Family Health Unit is similar in age and
gender distribution in turn to the population of Portugal
(Additional file 1, Appendix 1 - Comparison of the prac-
tice population with the Portuguese Population).
The Horizonte Family Health Unit is a group practice
formed by eight family physicians working together for
more than ten years with a stable registered population.
The change in the population of registered patients in the
practice between 2008 and 2009 was an increase of 1.88%.
There is a good accessibility to healthcare. Most patients
can be seen by any of the partners in case of their personal
doctor is absent with continuity of the electronic medical
record. The unit is a training practice for basic medical
education and postgraduate family medicine residency
training programmes. These characteristics of the practice
provide a unique opportunity for epidemiological studies.
An observational study was conducted between February
and July 2009 at the Horizonte Family Health Unit.
A stratified random sample by age and gender was
obtained from the practice general database of 13,568
registered patients.
Justification of age strata
The study population was divided into four age strata: 0
to 7 years, 8 to 19 years, 20 to 64 years and over 65 years.
The youngest age group of birth to 7 years was selected
to represent the age when asthma tends to be most pre-
valent and hospital admission rates are higher. The sec-
ond age group of 8 to 19 years was chosen to study the
period when mortality from asthma has been found to be
highest [34]. Adults aged 20 to 64 and the elderly aged 65
and over were studied separately because diagnostic pro-
blems regarding asthma are common in the elderly.
Sampling procedures
Based on the available published literature a prevalence of
asthma was predicted in this population for the four age
strata. In the 0 to 7 year age group a prevalence of 11%
was predicted, for 8-19 years 11.8%, for 20 to 64 years 5%,
and for over 65 years 5%. Using the method of Lehr [35], a
sample size calculation was performed to determine the
true prevalence of asthma in each age group plus or minus
2% with 95% confidence. In the 0 to 7 year age group 150
patients would be required, for 8-19 years 160 patients, for
20 to 64 years 140 patients, and for over 65 years 140
patients. Thus a sample of 590 patients would be required
in this population.
The required number of patients was selected from
each age group using the patient register in the practice
and a random number generator.
Data collection
Data were collected using two questionnaires: a physician’s
questionnaire (Additional file 2, Appendix 2 - Physician
Questionnaire) and a patient questionnaire (Additional file
3, Appendix 3 - Patient Questionnaire). The physician’s
questionnaire consisted of demographic information
including the age and gender of each of the selected
patients and clinical data on asthma. The first question
was “does this patient have asthma?” If the answer was
positive, the family doctor was required to answer four
sets of questions. The first questions asked about the pre-
sence of wheezing. The second set assessed a past or pre-
sent history of dry cough, recurrent wheeze, dyspnoea/
recurrent difficulty in breathing or recurrent chest tight-
ness. The third set of questions assessed the evidence of
reversibility of airflow obstruction after administration of a
short acting bronchodilator through clinical observation
only, peak flow measurement or spirometry. The fourth
question asked if a diagnosis of asthma had been made by
a secondary care specialist in case the diagnosis had not
been made by the family doctor alone.
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The patients’ questionnaire was based on the ISAAC
questionnaire [36] and consisted of demographic infor-
mation including age and gender and 13 questions on
asthma. Eight questions where about symptoms and
used the ISAAC core questionnaire for wheezing and
asthma. The first group of questions asked about the
presence of wheezing at present and specifically in the
last 12 months, the number of attacks of wheezing in
the last 12 months, wheezing during or after exercising,
and waking up because of wheezing or dry cough at
night in the last 12 months. Patients were asked if they
ever had asthma or if they had ever been told by a doc-
tor that they had asthma. The second section consisted
on five questions about medication. Questions were
asked on the use of any form of asthma medication in
the last 12 months and covered all the commercial alter-
natives available in Portugal including the colour and
the brand names of both inhalers and tablets. An algo-
rithm of diagnostic steps was used to make the diagno-
sis of asthma based on the responses obtained in the
study questionnaires (Figure 1).
In the first phase of the study, between February and
April 2009, all eight physicians in the health unit were
asked to report on each of the selected patients that
were seen during routine scheduled appointments for
any clinical reason. Each family doctor completed the
physician’s questionnaire. Each patient was invited to
answer a questionnaire based on respiratory symptoms
and signed an informed consent form.
In the second phase, between April and July 2009, all the
patients who had missed an appointment were contacted
by phone and invited for an interview with the researchers,
while the family physician was asked to fill in the doctor’s
questionnaire. Any patient who failed to answer the phone
after three attempts or refused to participate was replaced
by another patient with similar age and gender character-
istics (next random number in the same age group).
Patients who did not have any appointment during the
first phase were also contacted by phone.
The diagnostic procedures were based on a combination
of the answers given by the patient on respiratory symp-
toms and the physician’s best knowledge of the patient’s
asthma status. If the family doctor answered “no” to the
question “Does this patient have asthma?” and the patient
reported the absence of asthma symptoms, it was consid-
ered that asthma was not present. If the doctor answered
“yes” to the same question and the patient reported symp-
toms of asthma (“probable cases”), the diagnostic algorithm
was used (figure 1) in order to confirm or reject the diag-
nosis. In cases of inconsistency between the information
provided by the family doctor and the patient (“doubtful
cases”), an interview was conducted by the researchers
with an assessment of the patient to validate the diagnosis.
Data analysis
Data were entered on an electronic spreadsheet program
and analyzed using Epi-Info version 3.5.1 software. The
prevalence of asthma was calculated for the total popu-
lation and for specific age groups by dividing the num-
ber of cases found by the size of the population.
Standardized rates were computed using Portuguese
census data for 2005 [33].
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Figure 1 Steps to the diagnosis or exclusion of asthma in the asthma prevalence study
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In order to assess the predictive value of the items
used in the symptom questionnaire and the diagnostic
algorithm described above for a diagnosis of probable
asthma or doubtful asthma, odds ratios and 95% confi-
dence intervals were calculated using the Epi-Info
TABLES function. This was done to determine which
items in the history were most likely to be associated
with a final diagnosis of asthma.
Ethical approval
Prior to data collection, the study protocol was approved
by the Ethics Committee of the Local Health Authority
in Matosinhos (Unidade Local de Saúde de Matosinhos).
Each patient invited to participate signed an informed
consent form after the aims and methods of the study
were explained. All new cases of asthma or uncontrolled
cases found in the study were referred back to their
family physician for treatment.
Results
From the stratified random sample of 590 patients
selected from the population of the Horizonte Family
Health Unit, data were obtained from 576 patients (for a
response rate of 97.6%, Figure 2). The characteristics of
the study population are given in Table 1.
The mean age of this population was 33.2 years (sd =
28.1 years; 95% CI: 30.9 to 35.5), and 297 (51.6%) of the
patients in the sample were female.
Using the GINA criteria, asthma was diagnosed in 59
persons giving a prevalence of 10.24% (95% CI: 7.76 to
12.72).
A diagnosis of “probable asthma” was initially made in
37 patients (6.4%) and 102 patients were classified as
“doubtful cases”
Following a medical record review and interview of
doubtful cases, 22 were reclassified as asthmatic (for a
total of 59 cases), 514 as healthy and 3 (0.5%) remained
as doubtful cases.
The mean age for patients with asthma was 27.0 years
(sd 23.4, 95% CI: 21.0 to 32.9). For non-asthmatics the
mean age was 33.9 years (sd 28.5, 95% CI: 31.4 to 36.3).
This difference was not statistically significant.
The mean age for male patients with asthma was 22.0
years (sd 17.8; 95% CI: 15.5 to 28.5) with a median age
of 18.3 years. For males without asthma the mean age
was 33.4 (sd 27.7; 95% CI: 29 to 36) with a median age
of 19.7 years. This difference was statistically significant
(p < 0.05).
The mean age for female patients with asthma was
34.2 years (sd 28.9; 95% CI: to 41.5) with a median age
of 18.2 years. For females without asthma the mean age
was 34.5 (sd 29.2; 95% CI: 31 to 38) with a median of
19.3 years. This difference was not statistically
significant.
Female patients comprised 51.8% of the asthma
patients. There was no statistically significant difference
Population of
Horizonte Clinic
N=13568
Random Sample
N=590 (4.2%)
Responders
N=576 (97.6%)
Non-Responders
N=14
Probable Non-
Asthma
N=437
Probable Asthma
N=37
New Asthma Cases
N=22
Total Asthma Cases
N=59 (10.2%)
New Non-asthma
cases
N=77
Total Non-asthma
N=514
First look – patient questionnaire
Second look – physician evaluation
Final diagnosis
Possible Cases
N=102
Doubtful
N=3
Figure 2 Flow chart of patient recruitment and evaluation in asthma prevalence study.
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in the prevalence of asthma by gender for the total
population.
Among young children under the age of 8 years the
prevalence of asthma is higher in males (13%) than in
females (7%) but this difference is not statistically signif-
icant in this population (OR = 2, 95% CI, 0.6 to 6.9).
Among patients over 65 years of age the prevalence is
higher in females (7.3%) than in males (1.7%) but this
difference is not statistically significant (OR = 0.2, 95%
CI = 0.004 to 1.9).
Asthma prevalence by age group in the sample popu-
lation and standardized for the Portuguese population is
given in table 2.
Associations between symptoms and diagnosis
The association between positive symptoms elicited in
the patient questionnaire and a final diagnosis of asthma
was tested by computing the odds ratio (OR) for a posi-
tive reply comparing true cases of asthma with doubtful
cases (Table 3). The following items were found to be
statistically significant: wheezing after exercise (OR 4.2),
waking up from wheezing (OR 3.4), a personal history
of asthma (OR 12), being told by a doctor that the
patient has asthma (OR 14.6), use of a short-acting beta
agonist in last 12 months, (OR 35.6), use of a long-act-
ing beta agonist in last 12 months (OR 7.6), and the use
of an inhaled steroid in last 12 months (OR 25).
Discussion
This study found that the prevalence of asthma in the
population of the area covered by the Horizonte Family
Health Unit in Matosinhos, Portugal was 10.24% using
data collected from a random sample of the registered
population.
In Portugal, the composition of the population of
patients registered on the lists of general practitioners is
very similar to the general population living in the
region. This was described in a recent publication on
the incidence of asthma using general practice popula-
tions [37]. The population described in the general prac-
tice in current study is believed to be representative of
Matosinhos therefore these findings are believed to
represent the prevalence of asthma in this population.
Internal validity
The findings of this study are believed to represent the
true prevalence of asthma in this population. This is due
to use of a stratified random sample drawn from accu-
rate patient lists with a good response rate. In the case
of non-responders, replacements were drawn from a list
of alternates also produced by the random number gen-
erator. The use of accepted diagnostic criteria validated
by additional interview and examination by physicians
in cases of doubt regarding the diagnosis also increases
confidence in the quality of the data. In some age
groups the wide confidence intervals for the prevalence
of asthma is due to the small numbers of cases found. A
similar study in a larger population will resolve this
issue further.
Study questionnaire and diagnostic criteria
The patient questionnaire was based on the Portuguese
version of the ISAAC questionnaire which had been
previously used in Portugal as part of an international
Table 2 Asthma prevalence by age group in the sample population and standardized for the Portuguese population
Age groups Asthma Non-asthma Prevalence % 95% CI Prevalence % Standardized for Portuguese Population
0 to 7 13 123 9.56 5.41 to 13.71 8.6
8 to 19 21 139 13.13 8.74 to 17.52 13.1
20 to 64 18 122 12.86 8.21 to 17.51 12.3
≥ 65 7 133 5.00 1.97 to 8.03 6.3
Total 59 517 10.24 8.16 to 12.32
Total sample 576
(The three “doubtful cases” were included with the non-asthma patients in this table.)
Table 1 Demographic characteristics of study sample by gender, age and diagnosis
Total sample
N = 576
Mean age
Asthma cases
N = 59
Mean age
Non-asthma
N = 517
Mean age
33.2 years (s.d. 28.1) 27.0 years (s.d. 23.4) 33.9 years (s.d. 28.5)
Males 32.2 years (s.d. 27.1)
N = 279 (48.4%)
22.0 years (s.d. 17.8)
N = 29
33.4 years (s.d. 27.7)
N = 250
Females 34.2 years (s.d. 28.9)
N = 297 (51.6%)
31.8 years (s.d. 27.2)
N = 30
34.5 years (s.d.29.2)
N = 267
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study [4]. (The authors used only the relevant questions
about asthma symptoms from the questionnaire.)
The physician questionnaire was constructed using the
guidelines in the GINA 2006 Report [38]. Questions
were asked about the presence of wheezing, past or pre-
sent history of dry cough, recurrent wheeze, dyspnoea/
recurrent difficulty in breathing or recurrent chest tight-
ness and the evidence of reversibility of airflow obstruc-
tion after administration of a short acting
bronchodilator through clinical observation only, peak
flow measurement or spirometry. The same question-
naire was used in a study on the incidence of asthma
and accuracy of diagnosis in the Portuguese sentinel
practice network [37]. The utility of this questionnaire
in these two studies suggests that future study of asthma
prevalence could also use these diagnostic criteria.
Comparison of findings with other published studies
There are many published studies on the prevalence of
asthma but the absence of a precise and universally
accepted definition of asthma makes reliable comparison
of reported prevalence from different parts of the world
problematic [2].
Portuguese studies
The prevalence of asthma found in the present study for
the general population was considerably higher than
that found in previous studies in Portugal though differ-
ent methodologies and age groups have been used. Care
is required in comparison of these results with findings
from other studies. In the survey published in 1987 by
Nunes et al [24] for patients aged 7 to 17 years observed
regularly using a symptom score and spirometry, a pre-
valence of 3.4% was found. In 1990 Chieira et al [25]
studied 557 twenty year old male conscripts using a
questionnaire and clinical observation and found a pre-
valence of 5.2%. In 1991 Marques [39] studied a random
sample of 2000 inhabitants of the city of Porto aged 20
to 44 years using the ECRHS questionnaire and found a
prevalence of 4.3%. In 1992 Nunes et al [26] published a
report on 55,254 subjects in Algarve, Portugal using a
questionnaire and found a prevalence of 5.5% among
patients attending primary care consultations. In 1994
Alves et al [23] published the results of a survey in the
city of Porto using a postal questionnaire and found a
prevalence of 3.1% for the diagnosis of asthma and
6.45% for asthma symptoms in persons of both genders
aged 18 to 44 years. In 1994 Prata et al [27] studied 927
children 6-12 yrs old in Faial, Azores, and met a preva-
lence of 8.0%. In 1995 Vicente et al [28] studied 17,200
students aged 12-19 yrs living in eight major cities in
Portugal and found a prevalence of 3.2%. In 1996 Mor-
ais Almeida et al [29] used a questionnaire to study a
sample of 1,061 children aged 6-10 yrs in the Madeira
Island, Portugal and met a prevalence of 15%. In 1998
Leiria Pinto P et al [30] studied 1,334 adolescents aged
12-16 yrs living in Lisbon using a questionnaire and
found a prevalence of 11.4%.
The 2005 Portuguese National Health Survey [40]
found an overall asthma prevalence of 5.5%. The
method used for data collection was a home interview
of a stratified representative sample of the Portuguese
population with self-report on the conditions of interest.
In 2005 Branco et al [31] used a telephone interview
with a random sample of 1,211 households in mainland
Portugal and a total of 2,820 subjects of all ages as part
of a survey of chronic conditions. The prevalence of
self-reported asthma was 8.6%. Table 4 displays a com-
parison of asthma prevalence rates for all age groups
and methods in Portuguese surveys.
International studies
The comparison of the Matosinhos survey results with
other international data confirms that they are close to
Table 3 Odds ratios for the association of positive symptoms with a diagnosis of asthma
From the patients’ questionnaire, the following items were positive: Asthma cases (n = 59) Doubtful cases (n = 39) O.R. (95% CI)
Any history of wheezing 57 (96%) 38 (97%)
Wheezing in the last 12 months 40 (67%) 22 (26%)
Wheezing after exercise 19 (32%) 4 (10%) 4.2 (1.2-18.1)
Wake up from wheezing 23 (39%) 6 (15%) 3.4 (1.1-11.7)
Night time dry cough 40 (67%) 20 (51%)
Personal history of asthma 45 (76%) 8 (20%) 12 (4.2-37.9)
Told by a doctor they have asthma 47 (80%) 8 (20%) 14.6 (5-47)
Use of SABA in last 12 months 29 (49%) 1 (3%) 35.6 (5-1358)
Use of LABA in last 12 months 10 (17%) 1 (3%) 7.6 (1.00-345)
Use of Inhaled steroid in last 12 months 24 (40%) 1 (3%) 25 (3.7-1099)
Use of LABA-steroid in last 12 months 4 (7%) 1 (3%)
Use of leukotriene in last 12 months 11 (19%) 0
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published values. According to data from the World
Health Survey from 2003, [41] the prevalence of diag-
nosed asthma showed a narrow range across countries.
There was a 10-fold variation in current wheezing
symptom prevalence across countries (2.4% in Vietnam
and 24.3% in Brazil). The majority of estimates fell
within a fourfold range of prevalence, with Vietnam the
lowest at 1.8% and Australia the highest at 32.8%.
The 2003 Global Burden of Asthma document [3]
published on behalf of the GINA project compares the
mean prevalence of clinical asthma in different regions.
It ranges from 2.1% in Central North Asia (China/Tai-
wan/Mongolia) to 16.1% in the United Kingdom and
Republic of Ireland. Prevalences are higher in North
America, Oceania and West and Eastern Europe than in
Asia or Africa. Southern Africa (8.1%) and South Amer-
ica (9.9%) have intermediate prevalences. The prevalence
given for Western Europe (including Portugal) is 5.9%,
lower that the data from the Matosinhos study. These
studies have gathered data from different sources and
present a rather different range of values.
The most recent publications suggest that asthma pre-
valence ranges from 7.2% to 12.2%. In the U.S. National
Surveillance for Asthma study published in 2007 the
overall prevalence of asthma was 7.2% [42]. A Germany
study from 2005 by Stock et al [43] shows a total preva-
lence of asthma of 6.34% in the study population. A
study from South Australia from 2006 by Wilson et al
[44] shows that asthma prevalence increased from 7.5%
to 12.2% from 1990 to 2003. In a Swedish study from
2009 by Lötvall et al [45], asthma prevalence, defined as
asthma diagnosed by a physician, was 8.3%. In a Norwe-
gian study from 2003 by Brogger et al [46], the crude
prevalence of ever having had a doctor’s diagnosis of
asthma increased from 3.4 to 9.3% from 1972 to 1998-
99. Table 5 presents a comparison of published interna-
tional asthma prevalence rates.
Comparison of prevalence by age groups
In the United States National Surveillance for Asthma,
the prevalence rate among the birth to 4 year age group
was 5.9% [42]. A study among kindergartners in Chicago
public schools (mean age 5.7 yrs) found a prevalence of
asthma of 10.8% [47]. Data published by The Los
Angeles County Health Survey [48] shows a prevalence
of asthma in the birth to 5 years group of 5.9%.
Martinez et al. [49] studied wheezing before the age of
three years and the relation to wheezing at six years of
age and found that at the age of six years 13.7% of the
studied children had wheezing both before three and at
six years of age. Children with persistent wheezing had
significantly reduced lung function. According to data
from the New York State Asthma Surveillance, children
from birth to 4 years in New York State had an asthma
prevalence of 7.5% in 2006-2008 [50]. In a study carried
out in Asturias, Spain, asthma prevalence calculated for
infants was 7.6% [51]. In the Matosinhos survey, asthma
prevalence in the birth to 7 years age group was 9.59%,
close to figures found in published data.
In the study from 2008 by Ramos et al [32] in a sample
of 13 year old urban adolescents the lifetime prevalence of
asthma was 12.9%, with 84.4% of the diagnoses confirmed
by a physician. In the Matosinhos survey, the prevalence
in the age group 8 to 19 years was 13.13%. In the study by
Nunes [24] the prevalence for a similar age group (7 to 17
years) was 3.4%. Vicente et al [28] found a prevalence of
3.2% in those aged 12 to 19 years old. In the age group 20
to 64 years, our study showed a prevalence of 12.86%
while other Portuguese surveys found a prevalence of 3.1%
and 4.3% [23,39]. There were no Portuguese data found
for comparison of either the lower age groups (0 to 7
years) or for the elderly (over 65 years).
A Swedish study from 2006 [52] in children aged 7 to
8 years reported an increase in prevalence from 1996 to
2006 from 5.7% to 7.4%. In New Zealand the prevalence
of asthma is considerably higher. In the ISAAC Phase
Three study by Asher et al [53] repeating the question-
naire survey of two age groups of school children (6 to7
years and 13 to 14 years), the prevalence rates found
Table 4 Comparison of asthma prevalence rates for all age groups and methods in Portuguese surveys
Year Study Prevalence % Method
1992 Nunes et al [26] 5.5 Questionnaire
2005 Branco et al [31] 8.6 Self-report/Interview
2006 Portuguese National Health Survey [40] 5.5 Self-report/Interview
2009 Correia-de-Sousa et al 10.2 Questionnaire, self-report of symptoms
Table 5 International comparison of asthma prevalence
rates for all age groups
Year Study Country Prevalence
%
2003 Brogger et al [46] Norway 9.3
2005 Stcok et al [43] Germany 6.34
2006 Wilson et al [44] Australia 12.2
2007 National Surveillance for Asthma US
[42]
USA 7.2
2009 Lötvall et al [45] Sweden 8.3
2009 Correia-de-Sousa et al Portugal 10.2
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were 30.2% and 32.4% respectively. The results of Phase
III of the International Study of Asthma and Allergies in
Childhood (ISAAC) [12] in the age groups 6 to7 years
and 13 to 14 years provide data for international com-
parison of prevalence rates for asthma and wheezing.
The Portuguese data from this study show a mean life-
time prevalence of asthma in the age group 6 to7 years
of 9.8% and 13.2% for the 13 to 14 year age group.
These results are similar to our findings. The U.S.
National Surveillance for Asthma study [42] found the
prevalence to be 8.5% among those under 18 years and
6-7% for those over 18.
The U.S. National Health and Nutrition Examination
Survey (NHANES III) [54] found an asthma prevalence
on the age group over 20 years of 4.5%. In the Danish
survey by Browatzki et al [55] published in 2009, the
prevalence of self-reported asthma in the age group 20
to 35 years was 6.9%.
In the U.S. National Surveillance for Asthma study
[42] the lifetime prevalence of asthma in individuals
over 65 years of age was found to be 6.8%, though the
percentage of elderly patients with “current” asthma was
5.9%. In the NHANHES III survey [54], the prevalence
over 60 years was 3.6%. In our study, the prevalence for
the over 65 age group was 5%.
The comparison of the findings of the current study
with other studies computing lifetime prevalence of
asthma is relevant because the current study included
questions assessing if the patent had ever been told they
had asthma.
Comparison of asthma prevalence by gender
Some studies report a clear gender difference [52,56],
considering male gender to be associated with the
increased risk of asthma in children. Prior to the age of
14, the prevalence of asthma may be nearly twice as
great in boys as in girls [2].
In the present study there was no statistically significant
difference in the prevalence of asthma by gender, though,
among young children under the age of 8 years the preva-
lence of asthma is higher in males (13%) than in females
(7%) but this was not statistically significant. Branco et al
[31] also found no significant gender differences in asthma
prevalence. This study was most similar to the Matosinhos
survey. In some Portuguese surveys the overall prevalence
for females is higher than for males [39,40], while in other
the reverse was observed [32].
The U.S. National Surveillance for Asthma study [42]
shows a difference in prevalence by genders with 8.1%
among females and 6.2% among males. The report from
the ISAAC phase I and III studies in Spain [56] shows a
difference in prevalence by gender. In the age group 6
to 7 years, girls had 9.0% and boys 12.9%. In the age
group 13 to 14 years, girls had 11.8% and boys 13.8%.
The Danish study of the prevalence and severity of
asthma in young Danish adults over three decades
shows a higher female prevalence in all the three phases.
The female to male ratio was 1.7/1.2 in 1978, 4.8/4.5 in
1994 and 7.7/5.9 in 2004 [55].
Discussion of methods
Using the best knowledge about asthma from both the
patient and the physician was also used in a Swedish
study published in 2005. The authors concluded that a
combination of a medically verified asthma diagnosis
using medical records and the use of self-reported
symptoms with the ISAAC questionnaire seem to be
valid and reliable for the follow-up childhood asthma in
the community [57]. This is the method we chose for
diagnosis in our study and it seems to be a feasible
method for increasing diagnostic accuracy. It may
explain the higher prevalence found in our study com-
pared to other Portuguese studies.
Implications
The findings of the current study suggest that asthma
might have been under-reported in other epidemiologi-
cal studies in Portugal. This may also be true in other
countries. The use of accepted diagnostic criteria using
the best knowledge from both the doctor and the
patient may help to overcome this.
Careful assessment of symptoms can lead to more
accurate diagnosis of population. Skilful application of
this method in clinical practice may help to identify those
patients who may benefit from appropriate treatment.
Conclusions
Use of the best knowledge about asthma from both the
patient and the physician seems to be a good strategy
for the determination of the prevalence of asthma in a
community survey.
The prevalence of asthma found in the present study
was higher than that found in some studies, though
other studies have found a prevalence above 10%.
The prevalence of asthma in the birth to 7 age group
was lower than expected due to diagnostic problems.
Based on these data, assuming a prevalence of asthma
of 10%, with the current population of Portugal of
10,893,010 in 2011, we may expect 1,089,301 persons to
have asthma in Portugal.
Further studies in other regions of Portugal using the
same diagnostic criteria and sampling methods should
be done in order to confirm these findings.
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Abstract 
  
Background:  
There is evidence that self-assessment of asthma by patients and a stronger doctor-patient relationship 
can improve therapeutic compliance and improve asthma outcomes. Evidence is lacking on the 
influence of patient empowerment on the quality of life and control of asthma. The objectives of the 
current study were to assess asthma severity, medications, control, patient enablement and quality of 
life among asthmatic patients treated in primary care, and to study the relationship between 
enablement and quality of life. 
METHODS:  A cross-sectional study was conducted in an urban Family Health Unit in northern Portugal. 
Data were collected from both clinical records and questionnaires administered to a stratified random 
sample of asthma patients treated in this clinic. The Patient Enablement Instrument (PEI) the Asthma 
Quality of Life Questionnaire (AQLQ) and the Asthma Control Test (ACT) were used. Peak expiratory 
flow (PEF) and forced expiratory volume at one second (FEV1) were measured. The associations 
between patient empowerment, asthma control and quality of life were tested using logistic regression 
models. 
RESULTS: The study sample included 180 patients treated by 7 physicians. Persistent asthma was found 
in 57% and 43% had intermittent asthma. PEI scores were higher among patients with intermittent 
asthma compared to those with persistent forms (p<0.01). There was a strong correlation between 
asthma control and quality of life (r=0.81, p<0.001). Patient enablement did not correlate with the 
results of the pulmonary function tests. A weak but significant association between patient enablement 
and asthma control and quality of life was found in the logistic regression models. Poor control of 
asthma was associated with female gender, concomitant co-morbidities, reduced FEV1 and increased 
severity of asthma. Poor quality of life was associated with female gender and severity of asthma.  
CONCLUSIONS: The weak correlation between patient enablement and asthma control requires further 
study to determine if improved patient empowerment can improve asthma outcomes. This study 
shows how gender, severity and concomitant co-morbidities relate to asthma control and quality of 
life. It also confirms the strong correlation between asthma control and quality of life. 
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Introduction 
Asthma is a major public health problem and is one of the most prevalent chronic 
diseases in children and young people with significant effects on quality of life. Asthma 
prevalence and incidence are believed to be increasing. [1-3] Asthma is an important 
cause of hospital admission. It causes frequent distress at several levels, sometimes on 
a daily basis. It often affects the patient’s family and may cause considerable limitation 
of the patient’s normal daily activities.  
Patient empowerment and self-control of asthma have recently received more 
attention in the medical literature [4-6] as in other chronic diseases. [7, 8] 
One of the strategies proposed in the Global Initiative for Asthma (GINA) [2] to 
improve the control of the condition is the development of a partnership between 
physicians and other health professionals and patients with asthma, empowering 
patients to accept responsibility in the follow-up and self-control of their condition. 
The Portuguese National Asthma Control Program [9] was developed in 2000 in line 
with the GINA proposal. Its aim was to reduce the prevalence, morbidity and mortality 
related to asthma in Portugal and to improve the quality of life and well being of 
asthma patients. The Portuguese Guidelines for the diagnosis and control of asthma, 
based on the existing GINA Guidelines, [10] were also published in 2000 [11] and were 
updated in 2007 [12] after the 2006 changes in the GINA Report. The program and the 
guidelines recommend improvements in the efficacy and efficiency of the delivery of 
health care to asthma patients in order to promote self-control of their condition. [9, 
12] 
Well organised health teams practising patient centred care together with more 
enabled and more independent patients in the management of their condition may 
obtain better results in the control of some chronic diseases, lowering morbidity, 
mortality and the health costs. This has led to the development of global management 
programs for these diseases, such as the St. Vincent Declaration for diabetes mellitus 
in 1989, [13] the GINA program for asthma in 1993, [10] and the GOLD project for 
COPD in 1997.  [14] 
There is some evidence that training patients in self-assessment through the use of a 
peak flow meter and the recording of symptoms together with regular consultations 
with health professionals and a written action plan can improve the results of 
treatment in adults with asthma. [2, 15] 
Asthma control can be measured using the Asthma Control Questionnaire (ACQ) [16-
18] 
It is also important to assure the quality of life of patients with asthma. The Asthma 
Quality of Life Questionnaire (AQLQ) [21] has been translated and validated for use in 
the Portuguese population. [22, 23] 
or the Asthma Control Test (ACT). [19, 20] These questionnaires provide the patient 
and the physician with measures of the level of control of the disease and the need to 
adjust treatment. 
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Asthma has a negative effect on Health Related Quality of Life (HRQL). [24, 25] It is 
important to monitor this factor. The existing guidelines for asthma advise the 
involvement of patients in care through the use of flexible self-management plans, as 
often as possible. [26] Allowing the patients the opportunity to improve their 
knowledge and understanding of asthma can improve trust in their treatment, leading 
to better adherence to the therapeutic plan. 
Patients with asthma have often low expectations about control of the illness. They 
may adapt to the effects of poor control of asthma until they are given information 
that shows them that they can do better. Many patients are receptive to the use of 
written and personalised action plans. The implementation of such plans, supported by 
adequate education, and the improvement of health literacy can help patients to 
achieve a better control of asthma. [27] 
The Patient Enablement Instrument (PEI) is a tool to measure satisfaction with the 
result of consultations.  It was developed by Howie et al. in 1998. [28] Its purpose is to 
assess patient enablement in the control of an acute or chronic disease as a result of a 
consultation. It can also be used as a measure of the individual performance of a 
physician. While satisfaction is described in relation to the patient’s expectations, 
enablement is a condition where gains are obtained for the patient. Haughney et al. 
developed the mPEI, a modification of the Patient Enablement Instrument, for the 
assessment of enablement of patients with asthma. [29] 
The management of chronic diseases presents important challenges for doctors, 
including primary health care physicians. [30-32] It is possible that the model of patient 
centred health care in use in family medicine, [33] has fostered the development of 
more independent patients with a higher level of control over their disease. [34] 
International guidelines like the GINA project [2] suggest that a stronger doctor-patient 
relationship can improve adherence to treatment plans and lead to better results in 
asthma management.  It is necessary to identify the factors that influence the level of 
enablement and quality of life in a population of patients with asthma to test this 
hypothesis. 
The objectives of the current study were to assess the severity of asthma, medication 
use, asthma control, the level of patient enablement and the quality of life in a 
population of asthmatic patients treated in primary care, and to study the relationship 
between enablement and the quality of life of asthma patients. 
Method:  
Study population 
Matosinhos, is a suburb of the city of Porto in northern Portugal with a population of 
169,261 inhabitants in 2008. The age and gender distribution of the population of 
Matosinhos is similar to that of the total Portuguese population. [35] The population of 
the Horizonte Family Health Unit is similar in age and gender distribution in turn to the 
population of Portugal.   
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Practice Setting 
The Horizonte Family Health Unit is a group practice formed by eight family physicians 
working together for more than ten years with a stable registered population. There is 
good accessibility to healthcare. Most patients can be seen by any of the partners 
when their personal doctor is absent with continuity of the electronic medical record. 
The unit is a training practice for basic medical education and postgraduate family 
medicine residency training programmes. These characteristics of the practice provide 
a unique opportunity for clinical and epidemiological studies. 
The study questionnaire was pilot-tested in 20 patients to examine content and face 
validity between January and March, 2010. 
A cross-sectional study was conducted between February and November, 2010 at the 
Horizonte Family Health Unit.  
Sampling procedures  
A stratified random sample of asthmatic patients was obtained from the practice 
database of 450 asthmatic patients 18 years or older from the list of seven GPs. A 
diagnosis of asthma had been previously established by each of the family physicians. 
The definition of an asthma case for selection for the data base was made according to 
the GINA report [2] as explained in the paper published by the authors in 2010. [36] 
This data base had been used for several studies, and was therefore fairly accurate, 
though some minor inclusion errors had occurred. When patients were invited for the 
interview they also confirmed having asthma, either because they had previously been 
told so by their GP or another physician or were receiving asthma medication. A few 
patients that had been incorrectly selected for the data base and had other conditions, 
such as COPD, where excluded and replaced by the next subject in the sample. 
A random sample of 180 patients with asthma was obtained by simple replacement 
method using Randomizer.org. Patients with kyphoscoliosis, congenital or acquired 
absence of one lung, lung cancer, or cognitive impairment, pregnant or bedridden 
patients, or anyone unable to answer the questionnaire were excluded. There were 
five attempts to contact the selected patients. Whenever it was not possible to reach a 
selected person or patients were unable or unwilling to come to the practice for an 
interview, they were replaced by the next patient with the same age and gender from 
the list. 
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Questionnaires and tools 
The authors developed a questionnaire to collect demographic and clinical data from 
the interviews and used standardised questionnaires – the mini ACT, the modified PEI 
and MiniAQLQ. The demographic data was based on the questions that form the 
Graffar Social Classification, [37] a tool often used in Portuguese population studies. 
The clinical data section was based on the GINA classification of levels of severity and 
the several categories of drugs used to treat asthma. 
The Mini Asthma Quality of Life Questionnaire is a questionnaire designed for most 
patients to complete on their own. The questionnaire contains 15 items. All items are 
equally weighted. The overall Mini-AQLQ score is the sum of the scores for each item, 
divided by 15 (the number of items). The overall score is expressed as a score out of 7. 
A change in score of greater than 0.5 can be considered clinically important. [22, 38] 
The modified Patient Enablement Instrument adapted by Haughney et al. [29] to 
evaluate "enablement" in patients with asthma was used in the survey. The original 
English version was first translated to Portuguese and then back to English by two 
bilingual professional translators. The second translator did not read the original 
English text. The analysis of the back translation matched the original version. The 
resulting questionnaire was then applied to a pilot sample of 30 patients to asses the 
linguistic and cultural understanding of the questions and this was found to be 
satisfactory. A PEI score  ≥ 6 has been reported as indicating clinically meaningful 
enablement. 
The researchers have standardized the instructions for patients and these were asked 
to do at least three correct manoeuvres of FEV1 and PEF measurement, the best one 
being chosen. Manoeuvres were performed in standing position. No nose clip was 
used. 
Data collection 
Data were collected using medical records and a questionnaire produced by the 
authors. Participants were contacted by telephone or in person, informed about the 
research objectives and invited for an interview. Those who agreed to participate 
provided written informed consent. In case of difficulty in reading or understanding 
the questions, the investigator helped with the interview. 
The demographic data collected and analysed included gender, age, and social rank on 
the five-point Graffar scale. This scale includes questions about occupation, education, 
household income, housing, and social status of the neighbourhood. The severity of 
asthma was assessed according to the criteria defined by the GINA 2008 update. 
Medications used for relief and control of asthma were coded with the glossary of anti-
asthmatic therapy created by GINA. Asthma control was assessed as full control, partly 
controlled and uncontrolled using the mini Asthma Control Test, validated for patients 
over the age of twelve. Quantitative assessment of asthma control was made by 
measuring peak expiratory flow (PEF) and forced expiratory volume at one second 
(FEV1) using the Piko-1 spirometer which has been validated for use in Portugal. [39, 
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40] Concomitant comorbidities were counted. Quality of life was measured with the 
Mini-AQLQ (Asthma Quality of Life Questionnaire). 
Statistical analysis 
Data were collected, reviewed and coded into the spreadsheet program Microsoft 
Excel®.  For the statistical analysis the authors used EpiInfo ® (version 3.4) and the 
PASW Statistics for Windows ® (version 18.0). Data are presented by mean, median, 
standard deviation and range. Student t-test or the equivalent non parametric test of 
Man-Whitney were used for the comparisons between two groups. Several groups 
were compared using Analysis of Variance or the non parametric test of Kruskal-Wallis. 
Categorical data were analysed by the Chi-square test. Pearson and Spearman rank 
correlation coefficients were used to study the associations between several variables 
under study. Receiver Operating Characteristic Curve analysis was used to define a cut-
off on quality of life as a classification of good and poor asthma control. Logistic 
regression models were used to study the relation between several independent 
variables and the dependent variables quality of life and ahstma control. Statistical 
significance was set for p<0.05.  
Ethical approval 
Prior to data collection, the study protocol was approved by the Ethics Committee of 
the Local Health Authority in Matosinhos (Unidade Local de Saúde de Matosinhos). 
Each patient invited to participate signed an informed consent form after the aims and 
methods of the study were explained. All cases of uncontrolled asthma found in the 
study were referred back to their family physician for treatment. 
Results:   
From the stratified random sample of 180 asthma cases drawn from the clinic 
population, complete data were obtained from 175 cases for a response rate of 97.2%. 
The characteristics of the patient population are given in Table 1.  
The study population was composed of 68% female patients. The mean age of patients 
was 45.9 years, with a standard deviation of 17.1 years, a median age of 46.0 years, 
and a range of 18 to 83 years. Interaction between age and gender in the EQLAP study 
sample was tested using the Student t-test. The mean age for males was 41.1 years (sd 
16.2) and for females the mean age was 48.1 years (sd 17.2). The difference of seven 
years in the mean age between genders was statistically significant (p<0.05). Therefore 
it was necessary to control for age and gender in other analyses of association 
between predictor and outcome variables in this study. 
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Table 1: Characteristics of the study sample by gender and age 
 Males Females Total 
n (%) 56 (32%) 119 (68%) 175 
Mean age (years) 41.1 48.2 45.9 
Median age 38.0 49.5 46.0 
Mode 19 29 19 
Range 19 to 74 18 to 83 18 to 83  
Standard deviation 16.2 17.2 17.1 
The patients selected in the original sample who were unavailable for study (non-
responders) were analysed by age and gender to look for possible sources of bias. 
There were 38% males and 62% females among the non-responders which was similar 
to the gender distribution in the responders' group (Chi squared statistic =0.5, p>0.05). 
The mean age of non-responders was 48.1 years (sd 21.2) and the mean age of 
responders was 45.9 years (sd 17.1). This difference was found to be non-significant 
(p>0.05) by the Student t-test (Tables 2, 3 and 4). 
Table 2: analysis of responders by gender 
n (%) Males Females Total 
Responders 56 (32.0) 119 (68.0) 175 
Non-responders 32 (37.6) 53 (62.4) 85 
Total 88 172 260 
 
Table 3: mean age by responding  
 
n Mean 
Std. 
Deviation 
Responders 175 45.9 17.1 
Non-responders 85 48.1 21.2 
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Table 4: analysis of non-responders by reason for not participating in the study 
Reasons n % 
Unreachable 22 25,9 
Missed appointment / refused 21 24,7 
Other diagnosis / wrong 
diagnosis 15 17,6 
Other reasons 13 15,3 
Unable to attend appointment 12 14,1 
Deceased 2 2,4 
Total  85 100,0 
 
Key 
 
 
Unreachable Moved away from the practice. Wrong address or 
telephone. Away from home during the study period. 
Missed appointment / refused Had accepted when invited but never attended or 
refused when invited. 
Other diagnosis/ wrong diagnosis Had wrongly been labelled as having asthma or had 
another respiratory disease without asthma (COPD). 
Other reasons Not stated. 
Unable to attend appointment Due to old age, physical condition or  being bedridden,   
Deceased Died between randomisation and appointment. 
 
 
The study population was largely from a working class and middle class background 
with a mean Graffar score of 16 (sd 3.5). The distribution of the Graffar score by 
classes can be seen in table 5. 
 
Table 5: Characteristics of the study sample by classes of Graffar score 
 Class Score n % 
Class I Upper 5-9 7 4.0 
Class II Upper middle 10-13 33 18.9 
Class III Middle 14-17 73 41.7 
Class IV Lower middle 18-21 52 29.7 
Class V Lower 22-25 10 5.7 
 Total   175 100.0 
 
In terms of severity of asthma, most patients had intermittent asthma 42.9%, with 
mild persistent asthma diagnosed in 24%, moderate persistent asthma in 28.6% and 
severe persistent asthma in 4.6% (Table 6).   
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Table 6: Distribution of the patients in the sample by levels of severity of asthma   
Severity of asthma n % 95% confidence 
intervals 
Intermittent  75 42.9 36.7 to 49.0 
Mild persistent  42 24.0 18.7 to 24.3 
Moderate persistent  50 28.6 22.9 to 34.2 
Severe persistent 8 4.6 1.9 to 7.2 
Total 175 100.0  
Details of medication use are given in table 3 and 4. Short acting beta agonists were 
used as relief medication in 49.7% of the patients. No medication was required by 37% 
of the patients. The most common controller medication was a combination of an 
inhaled corticosteroid and a long acting beta agonist, used by 24% of the patients. 
Inhaled steroids alone were used by 14.9% of the patients. No controller medication 
was used by 49% of patients.  
Table 7: Relief medications used by the patients in the sample 
Relief Medication n  %  
Anti-Cholinergics 3  1.7  
None 66  37.7  
Other 19  10.9  
SABA 87  49.7  
Total 175  100.0  
Table 8: Control medications used by the patients in the sample 
Control Medication  n  %  
ICS   26  14.9  
ICS + LABA  42  24.0  
LABA  5  2.9  
Leukotriene inhibitors 1  0.6  
None  81  46.3  
Other  18  10.3  
Theophylline  2  1.1  
Total  175  100.0  
Comorbidities are shown in table 9. Concomitant comorbidity was found in 70% of 
patients with 48% of patients having only one additional comorbid condition. 
Coexisting comorbid conditions were found in 50% of patients with 27% having only 
one additional coexisting condition. Table 10 shows the distribution of the main 
comorbidities. 
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Table 9: Number and percentage of patients per number of concomitant and 
coexisting co-morbid conditions in the sample (n=175) 
Number of 
Concomitant 
co-morbidities 
n  %  
Number of 
Coexisting    
co-morbidities  
n  % 
0  54  30.9  0  88  50.3 
1  84  48.0  1  47  26.9  
2  27  15.4  2  19  10.9  
3  6  3.4  3  14  8.0  
4  3  1.7  4  5  2.9  
5  1  0.6  5  2  1.1  
Total  175  100.0  Total  175  100.0  
Table 10: frequency of the most common concomitant co-morbid conditions per 
total number of cases (n=175) 
Co-morbidities n  % 
Allergic rhinitis 69 39.4 
Obesity  30 17.1 
Smoking 25 14.3 
Sinusitis  16 9.1 
Allergy 8 4.6 
COPD 5 2.9 
Measurements of lung function included peak expiratory flow (PEF) and forced 
expiratory volume in 1 second (FEV1). The mean PEF in the study population was 372 
(sd 154) with a median of 52 and a range of 75 to 813. The mean PEF was 72.9% of the 
predicted value (median 75.6%) with values in the range of 18 to 171%. 
The mean FEV1 was 2.64 litres (sd 1.09) with a median of 2.57 and a range of 0.53 to 
5.91. The mean FEV1 was 92.8% of the predicted (median 92.7%) with the percent 
predicted ranging from 35% to 233%. In table 11, PEF and FEV1 values and percent of 
expected values from the sample patients are show. 
Table 11: PEF and FEV1 values and as percent of expected values in the sample 
patients. 
 n Minimum Maximum Mean Std. Deviation 
PEF 175 75 813 372.6 154.4 
Percent PEF 175 18.9 171.7 72.9 24.5 
FEV1 175 0.5 5.9 2.6 1.1 
Percent FEV1 175 35.2 233.0 92.8 25.3 
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With regard to measures of control of asthma, the Asthma Control Test had a mean 
score of 20.7 (sd 4.7) with a median of 22 and a range of 7 to 25. Asthma was not 
controlled in 51 patients (29.1%) and was partially or totally controlled in 124 patients 
(70.9%) (Table 12). 
Table 12: Distribution of the patients in the sample by levels of control of asthma 
Level of control of asthma n % 95% confidence 
intervals 
Controlled  43 25.1 19.8 to 30.5 
Partially controlled 81 46.3 40.1 to 52.5 
Uncontrolled 51 24.6 19.2 to 29.9 
Total 175 100.0  
Patient enablement was measured with the Patient Enablement Instrument with a 
mean score of 6.5 (sd 3.6) a median of 6 and a range of 0 to 12. A PEI score > 6 was 
found in 97 patients (55.4%), thus indicating a clinically meaningful enablement 
(Table 13). 
Table 13: Distribution of the patients in the sample by levels of enablement (mPEI) 
mPEI score n % 
Low (≤6) 78 44.6 
High (>6) 97 55.4 
Total 175 100.0 
Asthma quality of life measured by the Mini-AQLQ revealed a mean score of 5.6 (sd 
1.3) with a median of 5.87 and a range of 1.07 to 7.0 (Table 14).  
Table 14: Distribution of Mini-AQLQ in the sample patients 
 N Minimum Maximum Mean Std. Deviation 
Mini-AQLQ 175 1.1 7.0 5.6 1.3 
Bivariate analysis 
Bivariate analysis was performed to assess the relationship between variables. The 
main outcome variables such as severity, asthma control (ACT), quality of life (Mini-
AQLQ) and enablement (mPEI) were analysed in relation to the independent variables 
gender, age, socio-economic status (Graffar), concomitant and coexisting co-
morbidities, relief and control Medication and respiratory function measures (PEF and 
FEV1).  Figure 1 shows the relationship between variables that was analysed. 
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Figure 1: relationship between variables 
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Severity 
For purposes of analysis, severity was classified with the established scale mentioned 
in the introduction: intermittent, mild persistent, moderate persistent and severe 
persistent. In some analyses the two groups of moderate persistent and severe 
persistent asthma were combined to permit analysis with the chi squared statistic. 
Patients with more severe asthma have a lower level of control (Table 15 and Figure 
2). This difference is statistically significant (p<0.001). The assessment of severity of 
asthma and control are based on the presence of certain features such as symptoms or 
the use of medication. The table shows the relationship between the two 
classifications, though there is an overlapping of criteria contributing to their 
definition.  
Table 15: Control of asthma by levels of severity (n=175) 
Level of control 
Severity 
Intermittent 
Mild 
persistent 
Moderate 
persistent 
Severe 
persistent 
 n % n % n % n % 
Controlled 39 52.0 2 4.8 2 4.0 0 0 
Partially 
controlled 
29 38.7 27 64.3 24 48.0 1 12.5 
Uncontrolled 7 9.3 13 31.0 24 48.0 7 87.5 
Total 75 100.0 42 100.0 50 100.0 8 100 
Figure 2: Control of asthma by levels of severity (n=175) 
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Quality of life (mini-AQLQ score) is inversely proportional to the level of severity 
(Kruskal Wallis Test, Chi-square=64.257, p<0.001) (Table 16 and Figure 3). There are 
significant differences in quality of life between intermittent asthma and all the other 
forms of asthma, between severe persistent asthma and all other forms, but there is 
no significant difference between mild and moderate persistent asthma in terms of 
quality of life. Mann-Whitney Wilcoxon (Int-Mild Pers, Z=-5.300, p<0.001, Mild Pers –
Mod Pers, Z=-0.878, p>0.05; Mod Pers-Sev Pers, Z=-3.373, p<0.001) 
 
Table 16: Quality of life measured by Mini-AQLQ score by levels of severity (n=175) 
 
n Mean 
Std. 
Deviation 
Intermittent 75 6. 4 0.7 
Mild persistent  42 5.4 1.1 
Moderate 
persistent  50 
5.0 1.4 
Severe persistent  8 3.3 0.9 
Total 175 5.6 1.3 
 
 
Figure 3: Quality of life measured by Mini-AQLQ by levels of severity of asthma 
(n=175) 
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There is a statistically significant difference between the mean percent of predicted 
PEF and the level of asthma severity (Chi-square=20.19, p<0.001) (Table 17 and Figure 
4). There is a statistically significant difference between the mean percent of predicted 
FEV1 and the level of asthma severity (Chi-square=15.33, p<0.01) (Table18 and Figure 
5). Patients with severe persistent asthma have significantly lower percent of predicted 
PEF and percent of predicted FEV1 compared to patients with other degrees of 
severity. 
 
Table 17: Mean percent of predicted PEF by level of asthma severity 
 
n Mean 
Std. 
Deviation 
Intermittent 75 78..2 19.7 
Mild persistent  42 73.5 29.4 
Moderate 
persistent  50 
70.3 23.4 
Severe persistent  8 37.9 13.6 
Total 175 72.9 24.5 
 
Figure 4: Mean percent of predicted PEF by level of asthma severity 
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Table 18: Mean percent of predicted FEV1 by level of asthma severity  
 
n Mean% 
Std. 
Deviation 
Intermittent 75 98.0 18.8 
Mild persistent  42 95.9 33.3 
Moderate 
persistent  50 
87.2 22.3 
Severe persistent  8 62.6 25.1 
Total 175 92.8 25.3 
 
Figure 5: Mean percent of predicted FEV1 by level of asthma severity 
 
 
The distribution of patients between Severity and Control medication was not 
independent (Chi square=166.65, p>0.05). This means that patients with more severe 
asthma use more control medication (87.5%) when compared with patients with 
intermittent asthma (92.0% without medication). (Table 19, Figure 6). 
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Table 19: Severity by type of control medication  
   Control medication  
Severity  n (%) 
No 
medication ICS ICS + LABA OTHER Total 
Intermittent 69 (92.0) 2 (2.7) 2 (2.7) 2 (2.7) 75 (100.0) 
Mild Persistent 9 (21.4) 17 (40.5) 9 (21.4) 7 (16.7) 42 (100.0) 
Moderate 
Persistent 
3 (6.0) 7 (14.0) 30 (60.0) 10 
(20.0) 
50 (100.0) 
Severe Persistent 0 (0.0) 0 (0.0) 1 (12.5) 7 (87.5) 8 (100.0) 
Total 81 (46.3) 26 (14.9) 42 (24.0) 26 
(14.9) 
175 
(100.0) 
 
Figure 6: Severity by type of control medication
 
Severity of asthma is independent of gender, social economic status (Graffar), and the 
number of concomitant and coexisting co-morbidities.   
The analysis of variance showed that there was a significant difference between the 
mean age of the patients by severity using three classes (F=4.810, p<0.001) (Table 20). 
Patients in the severe and moderate persistent group were older than patients in the 
intermittent group (Tukey HSD). 
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Table 20: ANOVA age by severity 
 Level of severity n 
Mean 
age Std. Deviation 
Intermittent 75 41.4 15.9 
Mild Persistent  42 48.3 17.4 
Moderate + Severe 
Persistent  
58 50.0 17.4 
Total 175 45.9 17.1 
 
Asthma Control (ACT)  
The analysis of the level of control using the Asthma Control Test ACT was performed 
using three categories: controlled, partially controlled and uncontrolled, (for cut-off 
values of the ACT scores of 25, 20-24 and ≤ 19 respectively) or two categories: goo d 
control and poor control, (for cut-off values of  20-25 and ≤ 19 respectively). Analysis 
was done using the two methods,  
Males have higher ACT scores than females (Chi square= 8.803, p<0.01) (Table 21). 
Table 22 and Figure 7 show the mean age of patients in the three control classes.  
 
Table 21: Analysis of levels of control of asthma by gender (n=175)  
 ACT  
Gender  n (%) Good Control Poor Control Total 
Male 48 (85%) 8 (15%) 56 
Female  76 (64%) 43 (36%) 119 
Total 124 (71%) 51 (29%) 175 
 
Patients with a better control of asthma are younger (F=6.775, p<0.005). Post hoc tests 
(Tukey HSD) showed that age was significantly different between uncontrolled and 
controlled asthma. 
Table 22: Mean age by levels of control of asthma (three classes) 
Asthma control n Mean age Std. Deviation 
Controlled 43 38.9 16.1 
Partially controlled 81 46.1 16.9 
Uncontrolled 51 51.5 16.5 
Total 175 45.9 17.1 
 
19 
 
Figure 7: Age by levels of control (n=175)
 
When we consider the levels of control in two catergories, there is a significant 
difference between the mean age of patients with good and poor control of asthma 
(t=2.837, p<0.01) (table 23) with older patients having poorer asthma control.  
Table 23: Mean age by levels of control of asthma (two classes) 
Asthma Control  (ACT) n Mean Age Std. Deviation 
Good Control 124 43.6 16.9 
Poor Control 51 51.5 16.5 
 
As can be observed in table 24 and figure 8 the distribution of patients with 
concomitant co-morbidities is not independent of the levels of control of asthma (Chi 
square=12.06, p< 0.05). Patients with more co-morbidities have a lower level of 
control. In patients with uncontrolled asthma, 86.3% have at least one co-morbidity.  
Table 24: distribution of patients with concomitant co-morbidities by levels of 
control of asthma (ACT)  
 Concomitant co-morbidity  
Asthma Control ACT n (%) 
No co-
morbidity 
1 co-morbid 
condition 
2 or more 
co-morbid 
conditions Total 
Controlled 16 (37.2) 16 (37.2) 11 (25.6) 43 (100.0) 
Partially Controlled 31 (38.3) 38 (46.9) 12 (14.8) 81 (100.0) 
Uncontrolled 7 (13.7) 30 (58.8) 14 (27.5) 51 (100.0)  
Total 54 (30.9) 84 (48.0) 37 (21.1) 175 (100.0) 
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Figure 8: distribution of patients with concomitant co-morbidities by levels of 
control of asthma (ACT) 
 
Most patients without control medication are either controlled or partially controlled. 
Patients with more medication are more likely to be found in the partially controlled 
and uncontrolled groups. This difference in the distribution is statistically significant 
(Chi square=48.64, p< 0.05) (Table 25). 
Table 25: levels of control of asthma (ACT) vs control medication  
 Control medication  
Asthma Control ACT n 
(%) 
No 
medication ICS ICS + LABA OTHER Total 
Controlled 38 (88.4) 2 (4.7) 2 (4.7) 1 (2.3)  43 (100.0) 
Partially Controlled 34 (42.0) 13 (16.0) 22 (27.2) 12 (14.8) 81 (100.0) 
Uncontrolled 9 (17.6) 11  
(21.6) 
18 (35.3) 13 (25.5) 51 (100.0) 
Total 81 (46.3) 26 (14.9) 42 (24.0) 26 (14.9) 175 
(100.0) 
 
Most patients without relief medication are either controlled or partially controlled.  
There are more patients in the partially controlled or uncontrolled groups using relief 
medication (Chi square=22.43, p< 0.001) (Table 26). 
  
21 
 
Table 26: levels of control of asthma (ACT) vs relief medication  
 Relief medication  
Asthma Control ACT n (%) 
No 
medication SABA All Other Total 
Controlled 28 (65.1) 13 (30.2) 2 (4.7) 43 (100.0) 
Partially Controlled 27 (33.3) 45 (55.6) 9 (11.1) 81 (100.0) 
Uncontrolled 11 (21.6) 29 (56.9) 11 (21.6) 51 (100.0) 
Total 66 (37.7) 87 (49.7) 22 (12.6) 175 (100.0) 
 
Asthma control (ACT) is independent from socioeconomic status (Graffar). 
The analysis of variance showed that there was a significant difference between the 
mean percent of predicted PEF of the patients by level of asthma control (F=6.963. 
p<0.001) (Table 27). The mean percent of predicted PEF of the uncontrolled group was 
statistically different from the other groups. (Tukey HSD).  
Table 27: Asthma control (ACT) vs percent of predicted PEF 
  Percent predicted PEF  
Asthma control ACT n Mean % Std. Deviation 
Controlled 43 78.7 20.3 
Partially Controlled 81 76.4 25.0 
Uncontrolled 51 62.6 24.2 
Total 175 72.9 24.5 
The analysis of variance showed that there was a significant difference between the 
mean percent of predicted FEV1 of the patients by level of asthma control (F=7.299. 
p<0.001) (Table 28). The mean percent of predicted FEV1of the uncontrolled group 
was statistically different from the other groups. (Tukey HSD).  
Table 28: Asthma control (ACT) vs percent of predicted FEV1 
  Percent predicted FEV1  
Asthma control ACT n Mean % Std. Deviation 
Controlled 43 97.4 18.6 
Partially Controlled 81 97.3 26.6 
Uncontrolled 51 81.8 25.2 
Total 175 92.8 25.3 
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When we consider the relationship between asthma control and the number of 
concomitant co-morbidities, there is a significant difference between the mean ACT in 
patients without co-morbidities and those having one or more (t=3.256, p<0.01) (table 
29). 
Table 29: asthma control (ACT) vs number of concomitant co-morbidities 
Number of co-morbidities 
n Mean ACT score  
Std. 
Deviation 
No Concomitant  co-morbidities 54 22.2 3.5 
1 or more Concomitant co-
morbidities 
121 20.1 5.1 
 
Patient Enablement 
The level of patient enablement was measured using the modified Patient Enablement 
Instrument (mPEI). The established cut-off value for mPEI is 6, a value ≤6 meaning a 
Low Enablement and >6 a High Enablement. 
Bivariate analysis was performed to assess the association between mPEI and other 
measures of asthma control. No significant association was found between the mPEI 
score and the Mini-AQLQ score, the ACT score, the level of %FEV1, %PEF or asthma 
severity using ANOVA. 
The correlation between enablement (mPEI) and age was low (Figure 9) but when 
mPEI is studied in two classes, there is a significant difference between the mean age 
of patients with low and high levels of enablement (t=3.901. p<0.001) (Table 30 and 
Figure 10). There is a significant difference between the mean mPEI score in males and 
females (t=1.986. p<0.05) (Table 31 and Figure 11).  
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Figure 9: correlation between enablement (mPEI) and age  
 
 
Table 30: Mean age by levels of enablement 
PEI n Mean age Std. Deviation 
Low 78 40.5 15.3 
High 97 50.3 17.4 
Total 175 45.9 17.1 
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Figure 10: Mean age by levels of enablement  
 
 
 
Table 31: Mean mPEI score by gender 
Gender n Mean PEI score Std. Deviation 
Male 56 7.34 3.9 
Female 119 6.18 3.5 
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Figure 11: Mean mPEI score by gender 
 
There is no statistically significant difference between the mean mPEI score and the 
level of asthma severity - Kruskal Wallis Test (Chi-square=1.98057. p>0.05) (Table 32). 
 
Table 32: Mean mPEI score by level of asthma severity 
  mPEI  
Asthma control ACT n Mean  score Std. Deviation 
Intermittent 75 6.1 4.5 
Mild Persistent  42 7.3 2.5 
Moderate  
Persistent  
50 6.8 3.1 
Severe Persistent  8 5.4 1.9 
Total 175 6.5 3.6 
 
The mPEI score is lower with lower socio-economic status, though this was not found 
to be statistically significant association. 
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Quality of Life  
The analysis of variance of the relationship between quality of life (mini-AQLQ) and 
socio-economic status (Graffar) revealed that there is a statistically significant 
difference (F=4.07. p> 0.05). Post hoc tests (Tukey HSD) showed that mini-AQLQ was 
significantly different between the upper and lower social groups (Table 33) (Figure 
12). 
Table 33: Relationship between quality of life (mini Mini-AQLQ) and socio-economic 
status (Graffar) 
Graffar class  
n 
Mean AQLQ 
score 
Std. 
Deviation 
Upper 40 6.0 1.0 
Middle 73 5.6 1.3 
Lower 62 5.3 1.4 
Total 175 5.6 1.3 
 
Figure 12: Relationship between quality of life (mini-AQLQ) and socio-economic 
status (Graffar) 
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The correlation between quality of life (Mini-AQLQ) and age was weak (Figure 13). 
 
Figure 13: Correlation between quality of life (Mini-AQLQ) and age  
 
 
There is a significant difference of the Mini-AQLQ score (quality of life) by gender 
(t=5.54. p<0.001) (Table 34). 
 
Table 34: Mini-AQLQ score (quality of life) by gender 
Gender 
n 
Mean AQLQ 
score 
Std. 
Deviation 
Male 56 6.2 0.8 
Female 119 5.3 1.4 
 
 
The correlation between quality of life (Mini-AQLQ) and concomitant and coexisting 
co-morbidities, percent of PEF and percent of FEV1 was low.  
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Bivariate analysis of the relationship between outcome variables 
There was a strong and statistically significant correlation in this population between 
the scores on the ACT and the MINI-AQLQ (r=0.81. p<0.001). However, the correlations 
between mPEI and ACT and mPEI and MINI-AQLQ were weak. The scatter plots of 
these variables are given in figures 14, 15 and 16. 
Figure 14: relationship between asthma control test (ACT) scores and quality of life 
questionnaire (mini-AQLQ) scores in the EQLAP study (n=175)  
 
Figure 15: relationship between asthma control test (ACT) scores and mPEI scores in 
the EQLAP study (n=175) 
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Figure 16: relationship between quality of life (mini-AQLQ) scores and mPEI scores in 
the EQLAP study (n=175) 
 
 
The instrument used in the present study to measure asthma control was the Asthma 
Control Test. (ACT). The analysis of the level of control using ACT can be done using 
two or three categories. For the following analysis, two categories with a cut-off value 
of 20 (Good control = 20-25 and Poor control ≤ 19) was used.  
In order to establish a cut-off value for the quality of life measurement using the mini-
AQLQ, a ROC (Receiver Operating Curve) analysis was performed. Patients were 
classified in two groups (controlled and uncontrolled) according to ACT. Using this cut-
off, the distribution of Mini-AQLQ scores for the two groups was studied. Assuming 
that better control is related to a better quality of life, the ROC (Receiver Operating 
Characteristic Curve) analysis [41] provides the Mini-AQLQ cut-off that minimizes the 
misclassification of patients as controlled or uncontrolled as a function good and poor 
quality of life (Mini-AQLQ) (Figure 17). The cut-off value was fixed for a specificity and 
sensitivity of 80%. This analysis suggests that a Mini-AQLQ score less than 5.4 is related 
to a worse asthma control and lower quality of life and a score greater or equal to 5.4 
is related to a better control and higher quality of life (Figure 18). Area Under the 
Curve AUC= 0.878, 95%CI [0.821, 0.935]) 
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 Figure 17: ROC curve of mini-AQLQ vs ACT 
 
 
 
Figure 18: mini-AQLQ vs ACT 
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Logistic regression model 
Logistic regression models were constructed to assess the association between 
demographic and other predictor variables and asthma control (ACT) and quality of life 
(mini AQLQ) as outcome variables using a backward conditional method. The choice of 
the variables in the model was based on the bivariate analysis. The variables asthma 
control (ACT) and quality of life (mini AQLQ) were categorized in two levels: less than 
20 for ACT and less than 5.40 for mini AQLQ. 
The model coefficients for ACT are presented in table 8. The variables gender, socio 
economic status (Graffar), the number of concomitant co-morbidities, control 
medication, severity, enablement (mPEI), %PEF, %FEV1, age and relief medication 
were entered into the model.  
Model fit was assessed by the likelihood ratio statistic (Chi-square=61.220, d.f.=7, 
p<0.001) and by the Hosmer and Lemeshow test (Chi-square=6.047, d.f. = 8, p = 0.642). 
The logistic coefficients for all the variables are positive, indicating an increase in the 
log odds of being in poor asthma control. These values can be interpreted in terms of 
the odds ratio (OR), assuming that all other variables are held constant. 
Female gender is associated with poor control (OR=3.2). Severity is associated with 
poor control, with the more severe stages showing greater OR values (4.2 and 9.5, 
respectively, considering intermittent asthma as the reference class). A value of FEV1 
below 80% of the expected value is associated with poor control (OR=3.4). The analysis 
of concomitant comorbidities also shows that a higher number of comorbidities is 
related to a lower control (OR values of 4.2 and 5.6, respectively). Patient enablement 
(mPEI) appears to indicate that lower enablement is associated with poor control 
(Table 35) but this finding was not statistically significant (p=0.53).  
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Table 35: Logistic regression model for asthma control (ACT). Variables in the 
equation 
 
      
95% C.I. for 
EXP(B) 
 B S.E. Wald df Sig. EXP(B) Lower Upper 
Gender 1.2 0.5 5.3 1 0.022 3.2 1.2 8.8 
Concomitant co-
morbidities   
8.5 2 0.014 
   
1 concomitant co-
morbidity 
1.4 0.5 6.5 1 0.011 4.2 1.4 12.4 
2 or more concomitant 
co-morbidities 
1.7 0.6 7.3 1 0.007 5.6 1.6 19.5 
FEV1 < 80% 1.2 0.5 7.1 1 0.008 3.4 1.4 8.3 
Low mPEI 0.8 0.4 3.7 1 0.053 2.3 0.9 5.2 
Severity   17.8 2 0.000    
Moderate Persistent 
Asthma 
1.4 0.6 6.4 1 0.011 4.3 1.4 12.6 
Severe Persistent Asthma 2.2 0.5 17.8 1 0.000 9.5 3.3 26.9 
Constant -6.3 1.2 26.6 1 0.000 0.002   
 
The model coefficients for Mini-AQLQ are presented in table 36. The variables gender, 
socio-economic status (Graffar), severity and enablement (mPEI) were entered into the 
model. 
Model fit was assessed by the likelihood ratio statistic (Chi-square=49.917, d.f.=5, 
p<0.001) and by the Hosmer and Lemeshow test (Chi-square=3.980, d.f = 8, p=0.859). 
The logistic coefficients for all the variables are positive, indicating an increase in the 
log odds of being in poor asthma control.  
Female gender was associated with a worse quality of life (OR=3.8). Patients with 
moderate persistent and severe persistent asthma have a worse quality of life 
compared to patients with the reference condition, intermittent asthma (OR values of 
6.9 and 9.1, respectively). A low enablement (mPEI) appears to be associated with 
poor quality of life but this finding was not statistically significant (p=0.057, Table 36). 
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Table 36: Logistic regression model for quality of life (mini AQLQ). Variables in the 
equation 
 
      
95% C.I. for 
EXP(B) 
 B S.E. Wald df Sig. EXP(B) Lower Upper 
Gender 1.3 0.4 9.5 1 0.002 3.8 1.6 8.8 
Severity   26.1 2 0.000    
Moderate Persistent 
Asthma 
1.9 0.5 16.1 1 0.000 6.9 2.7 17.7 
Severe Persistent Asthma 2.2 0.4 23.9 1 0.000 9.1 3.8 22.1 
Low mPEI 0.7 0.4 3.6 1 0.057 2.0 0.9 4.2 
Constant -4.6 0.9 25.8 1 0.000 0.010   
 
Discussion:   
The current study found a strong association between asthma control and quality of 
life in a random sample of asthmatic patients cared for in general practice by seven 
general practitioners. A weak positive correlation was found between patient 
enablement and asthma control. 
Study questionnaire and diagnostic criteria  
The sample size was calculated in order to allow an adequate analysis of the study 
variables.  The results show that the sample size was adequate. The response rate was 
very high 97.2%, but 45 (25%) patients had to be replaced because they where 
impossible to reach, where away from their household during the study period, or 
where not willing to participate. An analysis of the non-responders by age and gender 
revealed that they were not significantly different from the responders so a response 
bias is unlikely. The analysis of the reasons for not participating does not show a 
probable bias, but this has to be considered as possible. 
As explained in the description of the methods, exclusion criteria were applied to 
patients with conditions that could influence the outcome variables or anyone unable 
to answer the questionnaire or perform respiratory tests because of cognitive 
impairment or illiteracy.  
The assessment of severity of asthma was based on the GINA Report update from 
2008. The GINA classification of severity has a number of limitations. According to the 
GINA guidelines, before treatment is initiated, asthma severity classification is based 
solely on clinical features. When patients are already receiving medication the 
classification of severity should be based on the clinical features present and the daily 
medication regimen. That was one of the reasons for GINA to move from a severity-
based to a control-based classification in 2006. [42] In the revised GINA guidelines, 
severity classification is regarded as suitable only for classification of patients who are 
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not on treatment. Though it is still controversial whether any classification system can 
be used to classify asthma severity reliably in patients receiving drug treatment, [43, 
44] using this approach it was possible to estimate the level of severity of the patients 
in the survey by matching the medication in use with the level of severity. Severity was 
classified this way in the present study. Considering that some patients might need to 
step-up or down treatment thus being classified at a higher or lower level, this might 
be a source of bias on the severity classification in the results. 
Though the modified Patient Enablement Instrument used in the survey was designed 
for self-administration, among patients with low literacy, help was required from the 
researchers in order to complete the form. If the researchers interpreted or explained 
the questions differently to different patients, this might be a possible source of inter-
observer bias.  
Most of the study instruments used here have good support in the published 
literature. However the validation of Portuguese version of the Asthma Control Test 
has not been published in a peer-review journal. There is a validated version published 
in Portuguese from Brazil [45] which uses a slightly different phrasing than the version 
in use in Portugal. [46] Several papers have used this version [47-50] and its clinical use 
is common both in secondary and primary health care so its use was considered 
trustworthy for this study.  
The Asthma Quality of Life Questionnaire (AQLQ) [21] has been translated and 
validated for the Portuguese population. [22, 23] 
A possible source of measurement bias is the skill required from patients to measure 
FEV1 and PEF. To reduce this effect, the researchers have used standardized 
instructions for patients as mentioned in the methods section. 
To analyse respiratory function the FEV1 and PEF values were entered in a database 
and the percentage was calculated against the expected values for gender, age and 
height.  
Comparison of findings with other published studies 
Severity of asthma and medication use 
In our survey, the study sample was obtained from a database of patients with doctor-
diagnosed asthma. All asthma patients were eligible to participate, whether they had 
intermittent or more severe forms of asthma. This may explain the difference in 
distribution by severity levels observed in the sample population compared to other 
studies. [51, 52] One survey used a different age range (15-45 years) with patients 
from a data base of primary health care centres employing a specialized asthma clinic 
which might only treat the more severe cases. [53] Another study used a large 
population from ten centres in eight countries. In that study an additional category of 
severity, asthma in remission, was used. [54] A Spanish survey from primary health 
care found a similar distribution of asthma severity as our study. [55]  
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Few recent studies were found describing the use of asthma medication in primary 
care patients. Most studies used a different classification of medication, making 
comparisons with the present survey difficult.  
Asthma control and quality of life 
The level of severity of asthma and the level of control are two correlated measures, 
but both concepts are important and conceptually distinct. In the study by Vollmer et 
al, the authors demonstrate that asthma control correlates strongly with both generic 
and disease-specific indices of quality of life. [56] 
The frequency of controlled and uncontrolled asthma described in the present study 
was found to be similar to the one achieved in an outpatient clinic from an allergology 
department in a central hospital in Portugal. [49] Though this represents a good 
outcome, we have to consider that patients with different levels of severity of asthma 
are being cared for in the two services and the age range was different.  
A Swedish survey by Ställberg et al., showed a similar level of uncontrolled asthma as 
the present study, though with a smaller number of partially controlled patients. [57]  
The existing literature has demonstrated a good relationship between asthma control 
and quality of life. [24, 25] The inclusion of patient-centred measures in monitoring 
asthma is important for guiding clinical management, predicting health outcomes, 
formulating clinical policy and assisting in the allocation of resources. [24] 
In a survey by Schatz et al., the authors used the ACT and the Mini-AQLQ to study the 
relationship between asthma-specific quality of life and asthma control and found that 
asthma control tools reflect the symptom and activity limitation aspects of quality of 
life. The control tools correlate well with emotional aspects but significantly less well 
than symptom or activity measures. [58] In the study by Lobo et al., asthma control 
measured by the Asthma Control Questionnaire is negatively correlated with all the 
quality of life variables. [59] 
Wijnhoven et al. report that the presence of co-morbid conditions is also associated 
with poor disease-specific health-related quality of life in asthma. [60] In their survey, 
in 25 general practices in three regions of the Netherlands, the authors report on the 
frequency of co-morbidities and assess the association between somatic co-morbidity 
and both disease-specific and general HRQoL in asthma and COPD patients aged 40-75 
years. The proportion of co-morbidities is not comparable to the ones in the EQLAP 
study, as a different classification was used. 
Enablement, asthma control and quality of life 
Evidence for the value of assessment of patient enablement in asthma is lacking.  A 
few studies have shown that training patients in self-assessment through the use of a 
peak flow meter and the recording of symptoms together with regular consultations 
with health professionals and a written action plan can improve the results of 
treatment in adults with asthma. [5, 6, 15] 
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Some authors found a good relationship between different features of patient 
enablement and good control of asthma. [15] A study by Thoonen et al. shows that 
most patients are interested in self-management plans. [61] This is not always the 
case. According to guidelines, inhaler technique should be tested in all patients, 
particularly those with poorly controlled asthma. However Hardwell et al. showed that 
despite training, a significant majority of symptomatic asthma patients in this study 
population were unable to use their prescribed pMDIs correctly. [62] 
Warsi A, et al. performed a systematic review and methodological critique of the 
literature and found that self-management education programs resulted in small to 
moderate effects for selected chronic diseases. [63] 
Doctors are poor at predicting patient satisfaction in the consultation. It is likely that 
satisfied patients are more likely to comply with treatment. It is important therefore 
that doctors develop ways of recognizing dissatisfaction during the consultation so 
that they may identify and address patients concerns. [64] 
Findings from a Dutch study by Thoonen et al., indicate that asthma control improved 
in patients treated by self-management when compared with individuals under usual 
care with an increase in the number of successfully treated weeks and fewer days of 
limited activity. [65]  
A study by Lavoie et al., found that lower levels of asthma self-efficacy defined as the 
patient’s confidence in their ability to avoid asthma exacerbations when exposed to a 
variety of triggering situations, were associated with worse asthma control and asthma 
quality of life. [66]  
The existing asthma guidelines recommend the involvement of patients through 
flexible self-management plans, as often as possible. Allowing the patients the 
opportunity to improve their knowledge and understanding of asthma can improve 
trust in their treatment, leading to better adherence to the therapeutic plan. [26] 
Patients are interested in using written action plans. When supported by adequate 
training they can help patients to attain a better control of asthma. [27] 
In a study from 2007, Haughney et al. describe a low correlation between the mPEI and 
the Mini-AQLQ but found a significant correlation between modified PEI total score 
and change in Mini Asthma Quality of Life Questionnaire. [29] These findings suggest 
that the mPEI is responsive to a change in a patient’s quality of life. 
Implications  
The findings of the current study suggest that patient enablement is associated with 
better asthma control and as such should be considered by clinicians as an additional 
tool in achieving clinical aims in asthma management. Further research is needed to 
determine if efforts to improve patient enablement result in improvements in asthma 
control and quality of life. The mPEI or similar instruments may be useful in future 
research in this area and may have application in routine clinical work as well. 
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Conclusions 
Patients registered with Family Physicians from Matosinhos achieved a good level of 
asthma control. Asthma was partially or totally controlled in 70.9% patients. 
A cut-off value for the score of the quality of life measurement using the Mini-AQLQ 
was established at 5.4.  
Patient enablement was found to be weakly associated with asthma control and 
quality of life in a population of asthmatics treated in primary care. There was a strong 
correlation found in this population between asthma control and quality of life. 
Physicians and patients may benefit from efforts to improve patient enablement in 
order to improve asthma care. 
The results show a mean score of the mPEI of 6.5, thus indicating a clinically 
meaningful “enablement”.  
This study showed that gender, concomintant co-morbidities, FEV1 and severity have a 
strong causal link with asthma control. With regard to quality of life, gender and 
severity are the main causal variables.  
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Discussion 
The present thesis was developed through three complementary surveys dealing with asthma 
incidence and prevalence, the variety of shapes and the different levels of severity of asthma in a 
clinical setting, together with characteristics from patients, including the level of enablement. The 
thread connecting the three studies was the understanding of how the burden of disease in the 
general population affects our capacity as clinicians to provide a good level of asthma control and 
offer a better quality of life to the patients in our care.  
Major findings 
The main findings of the surveys are:  
1. The annual incidence of asthma in the general population in Portugal was 2.02 
cases/1000/ year.  
2. The accuracy of the diagnosis by family physicians was 83.9%, using accepted diagnostic 
criteria.  
3. The use of the best knowledge about asthma from both the patient and the physician 
revealed to be a good strategy for the determination of the prevalence of asthma in a 
community survey.  
4. The prevalence of asthma by gender and stratified age groups the urban community studied 
was 10.24% using data collected from a random sample of the registered population. 
5. There was a statistically significant association between the presence of asthma symptoms 
and a final diagnosis of asthma for wheezing after exercise (OR 4.2), waking up from 
wheezing (OR 3.4), a personal history of asthma (OR 12), being told by a doctor that the 
patient has asthma (OR 14.6), use of a short-acting beta agonist  in last 12 months, (OR 
35.6), use of a long-acting beta agonist in last 12 months (OR 7.6), and the use of an 
inhaled steroid in last 12 months (OR 25). 
6. In a random sample of patients with asthma, most patients had intermittent asthma 42.9%, 
with mild persistent asthma diagnosed in 24%, moderate persistent asthma in 28.6% and 
severe persistent asthma in 4.6%.   
7. In the studied population, asthma was partially or totally controlled in 70.9% and not 
controlled in 29.1% patients. 
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8. There was a strong and statistically significant correlation (r=0.81; p<0.001) in the 
population studied between asthma control (measured through the ACT) and quality of life 
(measured with the Mini-AQLQ). 
9. It was possible to establish a cut-off value for the quality of life measurement using the Mini-
AQLQ, performing a ROC (Receiver Operating Curve) analysis. This analysis suggests that a 
mini AQLQ score <5.4 is related to a worse asthma control and lower quality of life and a 
score ≥5.4 is related to a better control and higher quality of life.  
10. It was possible to estimate the different degrees of enablement in the patient sample. The 
results showed a mean score of the mPEI of 6.5 (sd 3.6). A mPEI score    ≥ 6 was found in 
127 patients (72.8%), thus indicating a clinically meaningful enablement.  
11. From the results in the studies it was not possible to determine the factors that influence the 
level of enablement of patients with asthma due to probable bias and the sensitivity and 
specificity of the tool (mPEI). 
12. It was not possible to estimate the impact of enablement on morbidity in the patient 
sample.  
Internal validity  
The internal validity and main limitations of the studies have been discussed in the appropriate 
section in each paper. In the next section they are discussed in greater detail.  
Asthma incidence studies are not frequent in the literature, as the estimation of the incidence of 
asthma presents some methodological problems.81 These relate to the clinical awareness needed 
to identify the disease in a given patient. In epidemiological incidence studies in which the 
disease is easily diagnosed as it is marked by a major event, such as stroke or hip fracture, the 
time of diagnosis is easily established. For chronic diseases starting in an insidious, slow or 
progressive way, such as asthma, it is often difficult to establish when the disease started and 
the physician might only be able to mark the time when the diagnosis was recognized. In milder 
forms of asthma, such as intermittent or mild persistent, theses features might lead to 
considerable under-diagnosis, mostly due to under-presentation of respiratory symptoms by 
asthmatic patients to their family doctor. 94
One of the strong points of the system designed by the Portuguese Sentinel Network and other 
similar organisations in other parts of the world is a relatively stable denominator that can be 
used for epidemiological studies. The burden of frequent health problems in primary health care 
 The data in this study, therefore, might represent more 
doctor-diagnosed asthma than its true incidence. 
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can be studied this way. Incidence estimates and the use of medication and referrals are also 
common aspects studied in the PSPN. 
The clinical data gathered in every encounter by the physicians participating in the PSPN has an 
immense potential to produce relevant health information. Using a properly designed electronic 
patient record linked to a well structured health information system and a family practice-based 
research network could be a key instrument to study chronic conditions in the community. This 
combination of practice-based research tools can go much beyond the simple estimation of 
incidence and prevalence rates or the impact of diseases in the consultation, to a more sound 
clinical research network. It is possible to study the natural history of diseases, reasons for 
consulting, test ordering, prescription patterns, referrals, and many other topics. 
Portuguese family physicians have relatively stable patient lists. The age-gender distribution of the 
lists is updated yearly and reported to the PSPN coordination centre. The PSPN uses the 
physicians’ lists as a denominator for estimating incidence rates. Whenever participating doctors 
are absent for prolonged periods from their practices, their lists are removed from the 
denominator for statistical purposes. Nevertheless, problems have been reported with the 
accuracy of the patient lists of Portuguese family physicians, including duplicate registration of 
patients and failure to update lists following patient transfers and deaths, so some calculations 
might be imprecise due to these problems. 
A possible source of under-diagnosis could be that, in Portugal, younger asthmatic patients are 
often cared for by secondary care specialists, either in a hospital outpatient setting or in private 
consultations. As many of them are registered with a family physician and make frequent visits to 
the practice, the family doctor should have accurate information on the diagnosis, though asthma 
might not always be recorded in the medical records. Asthma is also often under-diagnosed in 
elderly patients as early symptoms of asthma often tend to be confused with symptoms of other 
chronic diseases such as COPD or cardiac insufficiency. 95
The diagnostic criteria for asthma used in this study were the criteria in the 2005 GINA 
guidelines. 
 Family physicians are in a unique 
position to distinguish these conditions as they know the natural history of the disease in their 
patients. 
96 The questionnaire was constructed using these guidelines but was not validated. 
Though this could be a source of instrument bias, it is based on sound clinical features and well 
established diagnostic criteria.   
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The findings of the survey “Asthma in an Urban Population in Portugal: A prevalence study” 
represent a good estimate of the prevalence of asthma in this population. A stratified random 
sample was drawn from accurate patient lists and there was a good response rate. In the case of 
non-responders, replacements were drawn from a list of alternates also randomly produced. The 
non-responders were studied and there were no demographic differences found between non-
responders and the study sample, but this could be a possible source of selection bias. 
The population described in the general practice in the current study is believed to be 
representative of Matosinhos therefore these findings most likely represent the prevalence of 
asthma in this population.  
The physician questionnaire was constructed using the guidelines in the GINA 2006 Report.97 
Questions were asked about the presence of wheezing, past or present history of dry cough, 
recurrent wheeze, dyspnoea/recurrent difficulty in breathing or recurrent chest tightness and the 
evidence of reversibility of airflow obstruction after administration of a short acting bronchodilator 
through clinical observation only, peak flow measurement or spirometry. The same questionnaire 
was used in a study on the incidence of asthma and accuracy of diagnosis in the Portuguese 
sentinel practice network.98
The same can be said for the patient questionnaire as no validation procedure was conducted 
prior to this study and this could be another source of instrument bias. However the patient 
questionnaire was based on questions from the ISAAC questionnaire, and these items have been 
previously used in Portugal, 
 Though its structure was simple, it is not a clinically, sociologically 
and culturally validated instrument. This might be a source of instrument bias.   
99
The use of accepted diagnostic criteria validated by additional interview and examination by 
physicians in cases of doubt regarding the diagnosis also increases confidence in the quality of 
the data.  
 as well as in many other international studies.  
Evidence of reversibility of airflow obstruction after administration of a short acting bronchodilator 
was a requirement but it could be obtained from clinical observation, such as improvement in 
wheezing after bronchodilation, significant improvement in PEF measurement or through 
spirometry performed in the clinic or in a certified laboratory.  
In some age groups the wide confidence intervals for the prevalence of asthma is due to the 
small numbers of cases found.  
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Some of the limitations of the study on enablement and quality of life in asthma patients 
addressed in this section have been previously dealt with in the discussion section of the study 
that was submitted for publication. In order to add to the general discussion of the thesis, some 
of these problems are clarified here.   
The limitations existing in the assessment of the levels of severity of asthma based on criteria 
from the GINA Report update from 2008 have already been addressed in the discussion section 
of the paper. A complementary approach was used by matching the medication in use with the 
level of severity. Considering that some patients might need to step up or step down treatment 
thus changing their classification to a higher or lower level, might be a source of bias in the 
classification of severity. 
Another limitation is the use of questionnaires that have not been validated. The cultural and 
sociological validations of the Asthma Control Test have not been published, though several 
Portuguese studies used the current format and its clinical use is common both in secondary and 
primary health care. Its use was considered reliable for this study. The modified Patient 
Enablement Instrument has not been validated for use in Portugal, though there were two 
forward and backward translations and a pilot study in a small sample to test its cultural 
understanding by patients.  
The distribution of levels of severity of asthma observed in the sample population is different from 
some other studies. One Spanish survey from primary health care found a similar distribution to 
that in our study. 
The proportion of controlled asthma described in the present study was found to be higher than 
that reported in the general Portuguese population in a preliminary report from a national 
survey.
100 
101
The existing literature has demonstrated a good relationship between asthma control and quality 
of life. 
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Problems with the mPEI  
 This was also one of the major findings in this study. 
There are few studies available in the scientific literature on patient enablement in asthma.   
During the preparation of the EQLAP study, the researchers were faced with the challenge of 
finding a valid and reliable tool to measure enablement. Haughney’s study from 2007 had 
developed the modified Patient Enablement Instrument. 45 This was the only existing validated tool 
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that allowed a quantitative measure of enablement. Haughney and colleagues are currently 
developing a new tool, the Aberdeen Asthma Questionnaire but this is not yet available. In a 
paper presented in the European Respiratory Society meeting in Stockholm, 2007, 105
In their study of the mPEI, Haughney et al had also found a low correlation between the mPEI 
and the Mini-AQLQ but found a significant correlation between the modified PEI total score and 
the change in Mini-Asthma Quality of Life Questionnaire score.
 they 
attempted to find out if enablement could be described and if so, if it could be measured by an 
appropriate tool.  Focus groups and a modified Delphi exercise involving people with asthma, 
health care professionals and researchers had been conducted to identify a meaningful 
vocabulary and to generate items for inclusion in the draft questionnaire. This resulted in a 13 
item draft questionnaire that was then tested amongst 102 people with asthma. The instrument 
was later reduced to seven items. Haughney has suggested that this new tool would solve some 
of the problems with the use of the mPEI, but the new instrument is not yet available. Thus the 
only available instrument for the measurement of patients’ enablement in asthma was the mPEI. 
45
The results from the EQLAP study show that the mPEI has considerable limitations. The 
correlation between enablement (mPEI) and age was low. However when the mPEI is studied in 
two classes, older patients have a significantly lower level of enablement. There is a significant 
difference between the mean mPEI score in males and females in the study sample, with males 
having higher mPEI scores.  
 These findings suggest that the 
mPEI is responsive to a change in a patient’s quality of life.  
In the bivariate analysis performed to assess the association between enablement (mPEI) and 
other measures, no significant associations were found with quality of life (Mini-AQLQ score), 
asthma control (ACT score), asthma severity or the level of %FEV1 and %PEF.  
Regarding the relationship between enablement (mPEI) and socio-economic status (Graffar), the 
results indicate that the mPEI score is worse in the lower socio-economic status groups, though 
there is not statistically significant. The correlation between the level of education and 
enablement assessed and no significant association was found. During the collection of data, 
some of the researchers found that patients with intermittent asthma that had been symptom-
free for long periods and not using asthma relief medication, mentioned that they could only 
answer the mPEI questions by scoring 0 (not applicable). This was based on the instructions 
provided by the researchers, following the instructions given in the original paper on the mPEI. 
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This might explain the low mPEI scores in patients with good asthma control and intermittent 
asthma who were not using control or relief medication. Some of the analysis performed might 
have been influenced by this fact. 
The analysis of data and the discussion of the findings from this study, suggest that the mPEI 
may be more appropriate for patients with persistent forms of asthma with measurements made 
before and after a consultation. This leaves some unanswered questions about the instrument 
and an open field for further research. 
A valid and reliable instrument is required to measure patient enablement. After translation and 
cultural validation, the Aberdeen Asthma Questionnaire could be a useful tool for research and 
clinical practice.  
Comparison of results with previous work 
The three surveys presented in this thesis have been published or submitted in the last 24 
months. Most of the comparison of the findings with other studies has been thoroughly discussed 
in the external validation section of those papers. In order to find more recent studies that could 
be compared with the studies included in this thesis, the candidate searched the literature with 
the appropriate MeSH terms. 
1. Asthma incidence and accuracy of  diagnosis in the Portuguese sentinel practice 
netw ork 
The date of submission of this paper was 30th July 2009. A literature search was performed the 
12th
The abstracts were evaluated to determine whether the studies would be of value to contribute 
further to the discussion. Many articles studied asthma in children pregnant women and other 
sub-groups, therefore were not eligible.  
 of June, 2011 using the combined keywords “asthma” AND “incidence” in the title and 
setting a time limit of 2009 to 2011. The search was done in Pubmed and Google Scholar and 
returned 19 and 31 articles respectively. There was overlapping of articles and Google Scholar 
returned several duplicates.   
One article was found that could be used for comparison. Gershon et al studied trends in asthma 
incidence in Ontario, Canada from 1996 to 2005 and concluded that the overall age- and sex-
standardized incidence rate of asthma had increased from 5.0/1,000 person years to 5.7/1,000 
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person-years. 106 
A second study provided valuable methodological information about the evaluation of the validity 
of the case definition and a description of the participants’ characteristics and health-care use 
patterns. It is a description of the organisation of an asthma incidence surveillance system using 
voluntary reporting of asthma by outpatient clinics and emergency departments. This study, 
however, does not contain additional data for comparison with the Portuguese Sentinel Practice 
Network survey. 
These rates are double the rate of 2.02/1,000 person years reported in the 
Portuguese Sentinel Practice Network survey. 
2. Asthma in an Urban Population in Portugal: A prevalence study. 
107 
The date of submission of this paper was 29 October 2010. A literature search was performed 
the 12th
The abstracts were appraised to decide whether the studies would be of value to contribute 
further to the discussion. Many articles studied asthma prevalence in children, workers, ethnic 
minorities or other sub-groups. All the surveys that dealt with prevalence in all age groups were 
selected. Some studies dealing with children that had similar age intervals to the ones in the 
Matosinhos sample were used for comparison. Fifteen papers were selected. The main findings 
from each study that are relevant for comparison are discussed in the following paragraphs. 
 of June, 2011 using the combined keywords “asthma” AND “prevalence” in the title and 
setting a time limit of 2010 to 2011. The search was done in PubMed and Google Scholar and 
returned 136 and 100 articles respectively. There was overlapping of articles and Google Scholar 
returned several duplicates.  
Asthma in all age groups 
During 2006–2008 the CDC analysed data from the National Health Interview Survey (NHIS) and 
estimated that 7.8% of the U.S. population had current asthma. Current asthma prevalence also 
was higher among children (9.3%) than among adults (7.3%) and among females (8.6%) than 
among males (6.9%). 
According to the US National Health Statistics Reports, in 2009, current asthma prevalence was 
8.2% of the U.S. population (24.6 million people); within population subgroups it was higher 
among females, children, persons of non-Hispanic black and Puerto Rican race or ethnicity, 
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persons with family income below the poverty level, and those residing in the Northeast and 
Midwest regions. 
Ekerljung et al assessed changes in the prevalence of asthma and respiratory symptoms in a 
defined study area in Stockholm, Sweden, using identical methods and report an increase in ever 
asthma from 8.7% in 1996 to 11.0% in 2007 and physician-diagnosed asthma from 7.6% to 
9.3%. 
109 
Another Swedish study was done in the regions of Gothenburg, Uppsala and Umeå in an age 
interval of 20–44 years. Subjects were surveyed both in 1990 (n = 8,982) and 2008 (n = 9,156). 
Current asthma rose from 6.0% to 8.0%. 
110 
Fukutomi et al conducted population-based surveys three times in the same region, in 1985, 
1999, and 2006, at Fujieda City, Shizuoka, Japan, and found that prevalences of lifetime asthma 
and current asthma had significantly increased from 1999 to 2006 (5.1% to 6.7%, and 1.5% to 
3.4%, respectively). 
111 
In an Italian study based on an adult representative national sample using information obtained 
from the Health Search Database from the Italian College of General Practitioners 6.10% of the 
entire population had asthma (5.49% of men and 6.64% of women). 
112 
A study was done in the Canaries, Spain to evaluate the prevalence of and risk factors for asthma 
and related conditions. The subjects completed a respiratory questionnaire, and underwent 
spirometry, bronchial hyperresponsiveness (BHR) test, skin tests and immunoglobulin E (IgE) 
measurements. The random sample included 593 subjects. The prevalence of 4.2% (95%CI, 2.5-
5.9) was found for asthma. 
113 
Al the figures from the previous studies are lower than the 10.24% (95% CI: 8.16 to 12.32) found 
in the Matosinhos survey (Table 2).  
114 
In the Australian study by Chittleborough et al the prevalence of asthma was 12.0% (95% CI: 11.1 
to 13.1), and was significantly higher among women (13.5%) than men (10.5%). Asthma was 
determined from spirometry and self-reported doctor diagnosis.  
Gershon et al studied trends in asthma prevalence in Ontario, Canada from 1996 to 2005 and 
concluded that the age- and sex-standardized asthma prevalence increased from 8.5% in 1996 to 
13.3% in 2005, a relative increase of 55.1% (P < 0.0001). 
115 
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The prevalence referred in these two studies is higher than that found in the Matosinhos survey 
where no statistically significant difference in the prevalence of asthma by gender for the total 
population was present (Table 2). 
Asthma in children and adolescents 
A cross-sectional study of 3,015 adolescents (13-14 years of age) was done in Fortaleza, Ceará 
State, Brazil, in public and private schools, using the protocol from the International Study of 
Asthma and Allergies in Childhood (ISAAC), in 2006-2007. Prevalence rates were 22.6% for 
asthma, with a predominance of females (p = 0.002). 
Two thousand and twenty-three Greek 9-10-year-old schoolchildren from Athens and Thessaloniki 
were included in the study. All participants followed the ISAAC-II protocol by questionnaire, skin 
prick testing and flexural dermatitis examination. Compared with Athens, the prevalence of 
lifetime asthma (11.5% vs. 7.7%, p=0.004) and atopic current asthma (3.2% vs. 1.6%, p=0.02), 
were higher in Thessaloniki. 
117 
Bjerg et al compared two population-based cohorts of 7 to 8-year olds from the same Swedish 
towns in 1996 and 2006 using parental expanded ISAAC questionnaires. There was an increase 
on the diagnoses of asthma from 5.7% to 7.4% (p = 0.010). 
117 
Bai et al studied the prevalence of asthma in children aged 0 to 14 years from Beijing, 
Chongqing, and Guangzhou and found 3.15%, 7.45%, and 2.09%, respectively. 
118 
A cross-sectional epidemiological study following ISAAC methodology, and using a written 
questionnaire was distributed in schools in the Autonomous Community of Galicia. The study 
sample included 6-7 year-old children and 13-14 year-old adolescents, all of them from Galician 
Health Areas. The estimated prevalence of asthma was 13.6% in younger children and 12.2% in 
adolescents. 
119 
A Portuguese survey was done in Lisbon in 2008. Parents of 900 students aged 5-12 years were 
invited to answer a questionnaire of the ISAAC. The prevalence of asthma was 5.6%. 
120 
In the Matosinhos survey, the prevalence of asthma in the 0 to 7 years was 9.56% (95% CI: 5.41 
to 13.71 and in the 8 to 19 years 13.13% (95% CI: 8.74 to 17.52). Table 3 shows the 
comparison of the Matosinhos survey with the other studies. 
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Table 2: International comparison of asthma prevalence rates for all age groups in surveys published in 
2010-11. Update of the Table 5 from the paper “Asthma in an Urban Population in Portugal”. 
Year 
122 
Study Country Prevalence % 
2011* Juliá-Serdá et al. Spain 114 4.2 
2008 Bjerg et al. Sweden 111 8.0 
2009 US National Health Statistics Reports. 109 USA   8.2 
2007 Ekerljung et al. Sweden 110 11.0 
2009* Chittleborough et al. Australia 115 12.0 
2009 Correia-de-Sousa et al. Portugal 122 10.2 
2006 Fukutomi et al. Japan 112 6.7 
2006-2008 National Health Interview Survey. USA 108 7.8 
2009 Cazzola et al. Italy 113 6.10 
2005 Gershon et al. Canada 106 13.3 
* Year the paper was submitted. The year of the survey could not be confirmed in the paper 
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Table 3: International comparison of asthma prevalence rates for children and adolescents in surveys 
published in 2010-11. 
Year Age group Study Country Prevalence % 
2008-2009 0 to 14 Bai et al. China (Guangzhou) 119 2.09 
2008-2009 0 to 14 Bai et al. China (Beijing) 119 3.15 
2008-2009 0 to 14 Bai et al.   China (Chongqing) 119 7.45 
2009 0 to 7 Correia-de-Sousa et al. Portugal (Matosinhos) 122 9.56 
2008 5 to 12 Pegas e tal. Portugal (Lisbon) 121 5.6 
2006-2007 6 to 7 López-Silvarrey-Varela et al. Spain (Galicia) 120 13.6 
2006 7 to 8 Bjerg et al. Sweden 118 7.4 
2009 8 to 19 Correia-de-Sousa et al. Portugal (Matosinhos) 122 13.13 
2000 - 2001  9 to 10 Papadopoulou et al. Greece 117 11.5 
2006-2007 13 to 14 López-Silvarrey-Varela et al. Spain (Galicia) 120 12.2 
2006 – 2007 13 to 14 de Luna et al. Brasil 116 22.6 
 
3. Enablement and quality of  life in asthma patients (the EQLAP study): a cross-
sectional study f rom a family practice 
No further studies were found to add to this section, as the relevant ones have been included in 
the discussion section of the survey. 
Clinical and scientific implications of the findings 
1. Asthma incidence and accuracy of  diagnosis in the Portuguese sentinel practice 
netw ork 
According to the data from this study, the diagnoses of asthma made by the family physicians in 
the research network were accurate in 84% of all reported cases, as confirmed by reference to 
the diagnostic criteria used. These findings suggest that well trained family physicians have the 
skill to identify patients with asthma and perform the recommended diagnostic procedures. 
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The incidence rate reported of 2.02 cases/1000/ year means that an average family physician 
with a list of 1800 patients, should expect to see three to four new patients with asthma every 
year.  
Based on data from the survey, for a population of 10,893,010 a figure of 22,004 new cases of 
asthma per year should be expected in Portugal.  
The implications of these figures at the secondary health care level are related to the increase in 
the required investigations to confirm diagnosis through spirometry, to perform tests to study 
allergies and to deal with some of the more severe forms of disease.  
Health authorities need to assess the increase in health costs at all levels, the human resources 
needed, the additional training required, the costs of diagnostic investigations, the increase in the 
use of treatment and, for a minority of uncontrolled patients, the use of emergency services and 
hospital admissions. 
2. Asthma in an Urban Population in Portugal: A prevalence study. 
The use of the best available information about asthma both from patients and the family 
physician has demonstrated to be a good approach to estimate with higher precision the 
prevalence of asthma in a community.   
The 10% prevalence of asthma found in the present study was within the expected interval. This 
is an important epidemiological result and can support local health authorities in the allocation of 
human and financial resources to deal with the problems.  
From the clinical management point of view, information about expected community prevalence 
can assist clinicians and practices in comparing results and increasing their awareness on the 
need for a better diagnosis of asthma. The discussion of the results from the survey at local level 
and the dissemination through publishing and the presentation at scientific meetings, have 
contributed to a wider perception of the burden of asthma in the community. 
Further studies in other regions of Portugal using the same diagnostic criteria and sampling 
methods should be done in order to confirm these findings.  
Based on data from this survey, assuming a prevalence of asthma of 10%, with the current 
population of Portugal of 10,893,010 in 2011, we may expect 1,089,301 persons to have 
asthma in Portugal. These figures might help National health authorities to develop plans to deal 
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with asthma and, due to its dimension, include asthma control as one of the main health 
problems requiring attention.  
3. Enablement and quality of  life in asthma patients (the EQLAP study): a cross-
sectional study f rom a family practice 
Asthma control was found to be associated with quality of life in a population of asthmatics 
treated in family practice. These findings reinforce the need for improvement in the care of 
patients with asthma in primary health care.   
The patients with asthma in the survey showed good degree of asthma control, as asthma was 
partially or totally controlled in 70.9%. Their family physicians have the capability to achieve a 
good level of care of asthma among their patients. These findings suggest that the care of most 
patients with less severe forms of asthma should be in the hands of well trained family 
physicians. 
A considerable number of patients with intermittent asthma did not report symptoms or the use 
of medication. In order to be sure that this is not due to a low level of self-awareness of 
symptoms, clinical record reviews should be performed at regular intervals, inviting these 
patients for appointments. The routine use of adequate clinical tools such as ACT, CARAT or 
Mini-AQLQ can support clinicians to achieve a more structured approach to the control of asthma 
in cooperation with other health professionals and enabled patients. 
The cut-off level established for the mini AQLQ can help researchers and clinicians to use this 
tool and include the assessment of quality of life in asthmatic patients as a routine, when caring 
for patients with more severe forms of the disease. 
The problems encountered with the use of the mPEI in assessing patient enablement did not 
allow any sound conclusions about the level of enablement of asthmatic patients in the survey. 
The observed lower level of enablement in some sub-groups, such as females, older, less 
educated and less wealthy patients, though not statistically significant, is clinically meaningful 
and supports research from other sources that physicians and patients may benefit from efforts 
to improve patient enablement in order to improve the care of chronic diseases such as asthma. 
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Conclusions 
The findings from the studies conducted suggest that Portuguese family physicians are skilled in 
diagnosing asthma with an accuracy of 84%. 
The annual incidence of asthma in the general population in Portugal was 2.02 cases/1000/ 
year.  
The use of the best knowledge about asthma from both the patient and the physician is a good 
strategy for the determination of the prevalence of asthma in a community survey.  
The prevalence of asthma in the urban community studied was 10.24%. 
Family Physicians from Matosinhos have the capability to achieve a good level of asthma control 
among their patients. Asthma was partially or totally controlled in 70.9%. 
Asthma control and quality of life are strongly correlated.  
A cut-off value for the score of the quality of life measurement using the mini-AQLQ was 
established at 5.4.  
The results show a mean score of the mPEI of 6.5, thus indicating a clinically meaningful 
enablement.  
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Suggestions for future research 
Since 1999, asthma and respiratory diseases have emerged as a natural field of research and 
academic development for me, while preserving interest and activity in other clinical, scientific 
and academic fields. I have since attended many scientific meetings and participated in 
organisations such as the Portuguese GINA Group, IPCRG, or the newly formed GRESP (the 
Portuguese respiratory interest group of family physicians). 
In my academic activity I was able to be a tutor of research projects of students from the 
University of Minho Medical School in the respiratory area. As a trainer of vocational trainees in 
family medicine, I also involved some of the trainees and young family physicians in research in 
respiratory problems in family practice. 
While developing the research presented in this thesis it was possible to incorporate new projects 
and research ideas and to develop some of them to guarantee continuity. 
Two projects have already emerged while this thesis was being written. 
1. Improving Care of Asthma Patients in Portugal through improvements in the electronic 
medical record: A proposal for a pilot study of new technology in Portuguese primary 
medical care. 
ICAPP-EMR “Improving Care of Asthma Patients in Portugal - Electronic Medical Record” 
is an asthma audit and review pilot study developed by the Department of Community 
Health of the School of Health Sciences of the University of Minho in conjunction with the 
International Primary Care Research Group (IPCRG) using electronic patient data to 
facilitate the flow of information between the patient and physician and to allow the 
monitoring of quality indicators in clinical practice. The objective of this study is to 
develop an effective tool for recording of asthma care in the electronic medical record 
and to determine if it is feasible in the National Health Service.  
Research questions: Does improved recording of asthma care using items from the 
IPCRG guidelines improve the outcomes of asthma control for asthma patients? Are 
patient compliance, concordance and enablement associated with better asthma control 
and outcomes?  
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Methods: A recording scheme for asthma care based on nationally accepted guidelines 
will be developed through a consensus method (adapted Delphi). This will include items 
in the patient’s history, physical examination, ancillary diagnostic tests, recording of the 
diagnosis, choice of treatment, patient concordance and follow-up. The researchers will 
assist computer programmers in the development of pilot software to be added to the 
electronic medical record currently in use Portuguese National Health Service. Special 
attention will be given to indicators of patient compliance, concordance and enablement. 
A sample of practices and doctors will be selected for participation in the study. A sample 
of asthma patients will be selected from each practice and the patient records will be 
reviewed to determine the number of items from the ideal record that are currently in the 
patient’s record. A random sample of participating practices will receive the new 
electronic asthma flow sheet and instructions on its use. A control group will continue 
with usual care.  
At the end of the study period, the charts of a sample of asthma patients will be reviewed 
to look for changes in recording patterns.  Evidence for differences in asthma control will 
also be assessed.  
Importance: If this instrument appears to be feasible and effective, it may contribute to 
the ease of asthma care by general practitioners and improve the quality of life for 
asthma patients.  
This may lead to a recommendation to the National Health Service Administration for the 
adoption of asthma control quality indicators and the addition of the asthma control tool 
in the Portuguese NHS electronic medical record. 
 
2. The second study was named Improving Care of Asthma Patients in Portugal through the 
development of Adherence, Concordance, and Enablement (ICAPP ACE).  
The researchers’ team will initially develop and validate translations and cultural 
adaptations of assessment tools such as the Modified Morisky Scale and the Aberdeen 
Asthma Questionnaire. The Control of Allergic Rhinitis and Asthma Test (CARAT) will be 
used to assess asthma control. 
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In a second phase, the team will develop a survey to study the relationship between 
patient compliance, concordance and enablement with better asthma control and 
outcomes. 
Importance: If these instruments appear to be useful, it may contribute to its use in 
practice thus assisting family physicians in understanding better their patients and 
improve the quality of life for asthma patients.  
This may lead to a recommendation to the National Health Service for the adoption of 
asthma quality of life instruments and the addition of the CARAT tool in the Portuguese 
NHS electronic medical record. 
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PORTUGUESE FAMILY PHYSICIANS STUDY ASTHMA RELATED CONSULTATIONS TO THEIR 
PATIENTS IN 2000-02 
 
J Correia-de-Sousa,
Horizonte Health Family Unit, Matosinhos, Porto, Portugal 
 M L Silva 
E-mail: jaime.siv@mail.telepac.pt 
Type of Paper
 
: oral presentation 
Aims: To calculate the incidence rate for asthma, quantify and assess the consultations related 
with asthma and the medication used for the treatment and control of asthma. 
Design: A cross-sectional study of asthma related consultations with patients from the family 
physicians’ (FP) lists from the Portuguese Sentinel Network in 2000-02. 
Results: The population under observation of the participating doctors lists was 329923 persons. 
5997 asthma related consultations were reported, a rate of 18.2 / 1000 inhabitants; 58.3 % 
were female patients. There was some variability on the number of cases per participating FP. 
The mean age of patients was 50.28 ± 0.6, with a gender difference. There were 422 new 
reported cases; therefore an incidence rate of 127.9 / 100000 inhabitants was estimated. The 
highest incidence rate was in the age group 0-4 years and the lowest in the over 75. In 66.1% of 
the consultations there was a prescription renewal, in 26.4% a follow-up, in 19.6% an acute 
episode was reported and in 7% there was a new case. The top therapeutic groups prescribed 
were inhaled b-2 agonists and steroids. 
Conclusion
 
: There was some variability on the number of cases per FP. The monthly incidence 
variation could be explained by the consultation rate differences. Incidence rate was somewhat 
lower than data found in the literature. 
 
